UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2017MARCH 31, 2023

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-54286001-41266

SURNACEA INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

Nevada27-3911608

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1780 55thSt.385 South Pierce Avenue, Suite C Boulder,

Louisville, Colorado80027

8030180027
(Address of principal executive offices)(Zip code)

(303)993-5271

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.00001 par valueCEADNasdaq Capital Markets
Warrants to purchase common stockCEADWNasdaq Capital Markets

 

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.YES [X] NO [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SS 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).YES [X] NO [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer, “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer[  ]Accelerated Filer[  ]
Non-accelerated Filer[  ]Smaller Reporting Company[X]
(Do not check if smaller reporting company)Emerging Growth Company[  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).YES [  ] NO [X]

As of November 10, 2017, there were 191,265,919May 15, 2023, the number of outstanding shares of the registrant’s common stock outstanding.of the registrant was 8,076,372.

 

 
 

TABLE OF CONTENTSCEA Industries Inc.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended March 31, 2023

Table of Contents

Page
Cautionary Note Regarding Forward-Looking StatementsStatementii
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)F-1
Unaudited Condensed Consolidated Balance Sheets as of September 30, 2017March 31, 2023 and December 31, 20162022F-12
Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2017March 31, 2023 and 2016March 31, 2022F-23
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the NineThree Months Ended September 30, 2017March 31, 2023 and 2016March 31, 2022F-34
Unaudited Condensed Consolidated Statements of Cash Flows for the NineThree Months Ended September 30, 2017March 31, 2023 and 2016March 31, 2022F-45
Notes to the Unaudited Condensed Consolidated Financial StatementsF-56
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations126
Item 3. Quantitative and Qualitative Disclosures About Market Risk833
Item 4. Controls and Procedures834
PART II — OTHER INFORMATION
Item 1. Legal Proceedings934
Item 1A. Risk Factors34
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds934
Item 3. Defaults Upon Senior Securities935
Item 4. Mine Safety Disclosures935
Item 5. Other Information935
Item 6. Exhibits935
SIGNATURES1036
EXHIBIT INDEX1137

i
 i

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the “Company”, “we”, “us” or “our” refer to CEA Industries Inc. and, where appropriate, its wholly owned subsidiary.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSSTATEMENT

This Quarterly Report on Form 10-Q, (this “Form 10-Q”)including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements withinthat involve substantial risks and uncertainties. These forward-looking statements are not historical fact but are based on current management expectations that involve substantial risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the meaningnegative of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).these terms or other similar words. All statements, contained in this Form 10-Q other than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives of management for future operations; any statements regarding ourcurrent or future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about futuremacroeconomic or industry-specific trends or events and the impact of those trends that we believe may affectand events on us or our financial condition, resultsperformance; any statements regarding pending investigations, legal claims or tax disputes; any statements of operations, business strategy, short-termexpectation or belief; and long-term business operations and objectives, and financial needs. any statements of assumptions underlying any of the foregoing.

These forward-looking statements are subject to a number ofknown and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment in which we operate. Important factors that could cause those differences include, but are not limited to:

our business prospects and the prospects of our existing and prospective customers;
the impact on our business and that of our customers of the lasting effects of the COVID-19 government response.;

our overall financial condition, including the impact of higher interest rates and inflation, business disruption due to the COVID-19 pandemic, the Ukraine war, and the supply chains on which we depend;

the impact on our business from our restructuring and cost containment actions taken in the first quarter of 2023;

the inherent uncertainty of product development and product selection to meet client requirements;
regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;
increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry and our engineering service and product supply position within the industry;
the ability to effectively operate our business, including servicing our existing customers and obtaining new business;
our relationships with our customers and suppliers;

ii

the continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments from our customers;
general economic conditions, our customers’ operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we operate;
the supply of products from our suppliers and our ability to complete contracts, some of which depend on other actors for a comprehensive project completion;
changes in our business strategy or development plans, including our expected level of capital expenses and working capital;
our ability to attract and retain qualified personnel;
our ability to raise equity and debt capital, as needed from time to time, to fund our operations and growth strategy, including possible acquisitions;

our ability to identify, complete and integrate potential strategic acquisitions;
future revenue being lower than expected;
our ability to convert our backlog into revenue in a timely manner, or at all; and
our intention not to pay dividends.

These factors should not be construed as exhaustive and should be read with the other cautionary statements in this report.

Although we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled “Risk“Item 1A – Risk Factors” in theour Annual Report on Form 10-K for the fiscal year ended December 31, 2016,2022, as updated from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”). Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It isYou should not possible for our management to predict all risks, nor can we assess the impact of all factorsplace undue reliance on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in anythese forward-looking statements, we may make. In lightwhich apply only as of these risks, uncertainties, and assumptions, the future events and trends discussed indate of this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in10-Q. Except as required by the forward-looking statements.

Wefederal securities laws, we undertake no obligation to revise or publicly release the results ofupdate any revision to these forward-looking statements, exceptwhether as required by law. Given these risksa result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking statements and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

Unless expressly indicated or the context requires otherwise, the terms “Surna,” the “Company,” “we,” “us,” and “our”projections contained in this Quarterly Report on Form 10-Q referare intended to Surna Inc., a Nevada corporation, and, where appropriate, its wholly owned subsidiary.be within the meaning of “forward-looking statements” in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”).

iii
 ii

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Surna

CEA Industries Inc.

Condensed Consolidated Balance Sheets

(in US Dollars except share numbers)

 2023  2022 
 March 31,  December 31, 
 September 30, 2017  December 31, 2016  2023  2022 
 Unaudited     (Unaudited)    
ASSETS                
Current Assets                
Cash and cash equivalents $1,300,706  $319,546  $15,948,077  $18,637,114 
Accounts receivable (net of allowance for doubtful accounts of $93,000 and $91,000 respectively)  274,762   47,166 
Notes receivable  -   157,218 
Accounts receivable, net  61,774   2,649 
Inventory, net  554,170   747,905   441,133   348,411 
Prepaid expenses  182,623   84,976 
Prepaid expenses and other  471,137   1,489,921 
Total Current Assets  2,312,261   1,356,811   16,922,121   20,478,095 
        
Noncurrent Assets                
Property and equipment, net  77,676   93,565   60,713   68,513 
Intangible assets, net  680,267   667,445   1,830   1,830 
Deposits  51,000   -   14,747   14,747 
Operating lease right-of-use asset  436,549   462,874 
Total Noncurrent Assets  808,943   761,010   513,839   547,964 
                
TOTAL ASSETS $3,121,204  $2,117,821  $17,435,960  $21,026,059 
                
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)        
LIABILITIES AND SHAREHOLDERS’ EQUITY        
                
LIABILITIES        
Current Liabilities                
Accounts payable and accrued liabilities $1,450,363  $1,337,853  $1,164,134  $1,207,258 
Deferred revenue  1,241,819   1,421,344   1,102,601   4,338,570 
Amounts due shareholders  21,676   57,398 
Convertible promissory notes, net  -   761,440 
Convertible accrued interest  -   161,031 
Derivative liability on warrants  265,760   477,814 
Accrued equity compensation  -   89,970 
Current portion of operating lease liability  120,245   118,235 
Total Current Liabilities  2,979,618   4,216,880   2,386,980   5,754,033 
                
Noncurrent Liabilities                
Amounts due shareholders-long term  -   11,985 
Operating lease liability, net of current portion  348,179   376,851 
Total Noncurrent Liabilities  -   11,985   348,179   376,851 
                
TOTAL LIABILITIES  2,979,618   4,228,865   2,735,159   6,130,884 
                
SHAREHOLDERS’ EQUITY (DEFICIT)        
Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 77,220,000 shares issued and outstanding  772   772 
Common stock, $0.00001 par value; 350,000,000 shares authorized; 189,865,919 and 160,744,916 shares issued and outstanding, respectively  1,898   1,607 
Commitments and Contingencies (Note 6)  -   - 
        
SHAREHOLDERS’ EQUITY        
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding  -   - 
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively  81   80 
Additional paid in capital  18,027,715   12,222,789   49,410,899   49,173,836 
Accumulated deficit  (17,888,799)  (14,336,212)  (34,710,179)  (34,278,741)
Total Shareholders’ Equity (Deficit)  141,586   (2,111,044)
Total Shareholders’ Equity  14,700,801   14,895,175 
                
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY(DEFICIT) $3,121,204  $2,117,821 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $17,435,960  $21,026,059 

SeeThe accompanying notes to the unauditedare an integral part of these condensed consolidated financial statements.

2
 F-1

SurnaCEA Industries Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)(in US Dollars except share numbers)

  For the Three Months Ended  For the Nine Months Ended 
  September 30,  September 30, 
  2017  2016  2017  2016 
Revenue $1,566,256  $1,170,760  $4,901,241  $5,560,837 
                 
Cost of revenue  1,175,047   753,624   3,668,698   3,742,321 
                 
Gross profit  391,209   417,136   1,232,543   1,818,516 
                 
Operating expenses:                
Advertising and marketing expenses  168,476   45,177   484,418   155,172 
Product development costs  60,145   75,144   250,228   275,370 
Selling, general and administrative expenses  1,396,957   533,694   3,518,528   1,559,070 
Total operating expenses  1,625,578   654,015   4,253,174   1,989,612 
                 
Operating income (loss)  (1,234,369)  (236,879)  (3,020,631)  (171,096)
                 
Other income (expense):                
Interest and other income, net  1,016   10,576   3,808   19,060 
Interest expense  -   (89,203)  (41,233)  (282,657)
Amortization of debt discount on convertible promissory notes  (10,037)  (291,000)  (63,157)  (1,335,429)
Loss on extinguishment of debt  (228,428)  -   (643,428)  - 
(Loss) gain on change in derivative liabilities  (6,660)  (62,000)  212,054   (348,297)
Total other income (expense)  (244,109)  (431,627)  (531,956)  (1,947,323)
                 
Loss before provision for income taxes  (1,478,478)  (668,506)  (3,552,587)  (2,118,419)
                 
Provision for income taxes  -   -   -   - 
                 
Net loss  (1,478,478)  (668,506)  (3,552,587)  (2,118,419)
                 
Other comprehensive income (expense)  -   -   -   - 
Comprehensive loss $(1,478,478) $(668,506) $(3,552,587) $(2,118,419)
                 
Loss per common share – basic and dilutive $(0.01) $(0.00) $(0.02) $(0.02)
                 
Weighted average number of shares outstanding, both basic and dilutive  184,912,253   145,268,135   179,470,179   139,684,359 

(Unaudited)

See

  2023  2022 
  

For the Three Months Ended

March 31,

 
  2023  2022 
Revenue, net $4,682,573  $1,744,427 
         
Cost of revenue  3,829,297   1,653,919 
         
Gross profit  853,276   90,508 
         
Operating expenses:        
Advertising and marketing expenses  202,323   251,015 
Product development costs  76,413   138,918 
Selling, general and administrative expenses  1,020,702   1,311,777 
Total operating expenses  1,299,438   1,701,710 
         
Operating loss  (446,162)  (1,611,202)
         
Other income (expense):        
Other income (expense), net  5,704   185,000 
Interest income (expense), net  9,020   3,260 
Total other income (expense)  14,724   188,260 
         
Loss before provision for income taxes  (431,438)  (1,422,942)
         
Income taxes  -   - 
         
Net loss $(431,438) $(1,422,942)
         
Convertible preferred series B stock dividends  -   (35,984)
Deemed dividend on convertible preferred series B stock on down round  -   (439,999)
         
Net loss available to common shareholders $(431,438) $(1,898,925)
         
Loss per common share – basic and diluted $(0.05) $(0.41)
         
Weighted average number of common shares outstanding, basic and diluted  8,071,731   4,622,427 

The accompanying notes to the unauditedare an integral part of these condensed consolidated financial statements.

3
 F-2

SurnaCEA Industries Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit)

For the NineThree Months Ended September 30, 2017March 31, 2023 and March 31, 2022

(Unaudited)(in US Dollars except share numbers)

(Unaudited)

  Preferred Stock  Common Stock          
  Number of Shares  Amount  Number of Shares outstanding  Number of Shares to Be Issued  Amount  Additional Paid in Capital  Accumulated Deficit  Shareholders’ Deficit 
Balance December 31, 2016  77,220,000  $772   160,744,916   -  $1,607  $12,222,789  $(14,336,212) $(2,111,044)
Common shares issued for conversion of debt and interest, net of unamortized debt discount  -   -   10,601,554   -   106   1,751,049   -   1,751,155 
Value attributed to modification of warrants  -   -   -   -   -   59,000   -   59,000 
Common shares issued with convertible notes payable  -   -   250,000   -   3   39,127   -   39,129 
Common shares issued for cash, net  -   -   16,781,250   -   168   2,684,832   -   2,685,000 
Fair value of warrants issued and options granted for compensation  -   -   -   -   -   415,570   -��  415,570 
Common shares issued as compensation for services  -   -   1,711,891   1,200,000   17   398,758   -   398,775 
Common shares to be issued in settlement of restricted stock units awarded as compensation for consulting services     -       200,000      20,500      20,500 
Fair value of vested restricted stock units awarded to employees and directors  -   -   -   -   -   218,677   -   218,677 
Fair value of vested stock options granted to employees  -   -   -   -   -   217,411   -   217,411 
Other common shares  -   -   (223,692)  -   (2)  2   -   - 
Net loss  -   -   -   -   -   -   (3,552,587)  (3,552,587)
Balance September 30, 2017  77,220,000  $772   189,865,919   1,400,000  $1,898  $18,027,715  $(17,888,799) $141,586 
  

Number of

Shares

  Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders  ’

Equity

 
  Common Stock  

Additional

     
  

Number of

Shares

  Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders  ’

Equity

 
Balance December 31, 2022  7,953,974  $80  $49,173,836  $(34,278,741) $       14,895,175 
Balance  7,953,974  $80  $49,173,836  $(34,278,741) $       14,895,175 
Fair value of vested stock options granted to employees  -   -   135,748   -   135,748 
Common shares issued in settlement of restricted stock units issued to directors  123,398   1   (1)  -   - 
Fair value of restricted stock units issued to directors  -       101,316       101,316 
Net loss  -   -   -   (431,438)  (431,438)
Balance March 31, 2023  8,077,372  $ 81  $49,410,899  $(34,710,179) $14,700,801 
Balance  8,077,372  $ 81  $49,410,899  $(34,710,179) $14,700,801 

  

Number of

Shares

  Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Equity

(Deficit)

 
  Common Stock  

Additional

    

Shareholders’

 
  

Number of

Shares

  Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Equity

(Deficit)

 
Balance December 31, 2021   1,600,835  $16  $25,211,017  $(28,781,566) $(3,570,533)
Balance   1,600,835  $16  $25,211,017  $(28,781,566) $(3,570,533)
Fair value of vested stock options granted to employees  -   -   32,938   -   32,938 
Fair value of vested stock options granted to directors  -   -   29,656   -   29,656 
Common shares issued in settlement of restricted stock units issued to directors  3,367   -   24,994   -   24,994 
Fair value of restricted stock units issued to directors  -   -   4,928   -   4,928 
Issuance of common shares to round up partial shares following reverse split  6,798   -   -       - 
Common shares and warrants issued for cash  5,811,138   58   21,711,073   -   21,711,131 
Common shares issued and warrants on conversion of series B preferred stock  362,306   4   1,979,996   -   1,980,000 
Dividends on series B preferred stock  -   -   (35,984)  -   (35,984)
Net loss  -   -   -   (1,422,942)  (1,422,942)
Balance March 31, 2022  7,784,444  $78  $48,958,618  $(30,204,508) $18,754,188 
Balance  7,784,444  $78  $48,958,618  $(30,204,508) $18,754,188 

SeeThe accompanying notes to the unauditedare an integral part of these condensed consolidated financial statements.

4
 F-3

SurnaCEA Industries Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)(in US Dollars except share numbers)

  For the Nine Months Ended 
  September 30, 
  2017  2016 
Cash Flows from Operating Activities:        
Net loss $(3,552,587) $(2,118,419)
         
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:        
Depreciation and intangible asset amortization expense  34,087   43,870 
Amortization of debt discounts on convertible notes  38,433   1,335,429 
Amortization of original issue discount on notes payable  25,520   - 
(Gain) loss on change in derivative liability  (212,054)  348,297 
Compensation paid in equity  1,270,933   4,028 
Provision for doubtful accounts  1,715   44,127 
Provision for excess and obsolete inventory  208,801   - 
Loss on sale of assets other  -   1,117 
Loss on extinguishment of debt  643,428   - 
Changes in operating assets and liabilities:        
Accounts and note receivable  (207,205)  186,945 
Inventory  (15,066)  345,316 
Prepaid expenses  (119,753)  17,211 
Accounts payable and accrued liabilities  112,516   (864,937)
Deferred revenue  (179,525)  434,529 
Accrued interest  (10,574)  282,657 
Deferred compensation  -   (25,600)
Cash (used in) provided by operating activities  (1,961,331)  34,570 
         
Cash Flows From Investing Activities:        
Cash disbursed for patent fees  (16,454)  (22,380)
Purchase of property and equipment  (14,566)  (15,126)
Proceeds from the sale of property and equipment  -   32,600 
Cash disbursed for lease deposit  (51,000)  - 
Cash disbursed for note receivable  -   (80,000)
Cash received from repayment of note receivable  157,218   100,000 
Cash provided by investing activities  75,198   15,094 
         
Cash Flows From Financing Activities:        
Proceeds from exercise of stock options  -   358 
Cash proceeds from sale of common stock and warrants  2,685,000   - 
Payments on convertible notes payable  (270,000)  - 
Proceeds from issuance of notes payable  500,000   - 
Payments on loans  -   (34,115)
Payments on loans from shareholders  (47,707)  (111,009)
Cash provided by (used in) financing activities  2,867,293   (144,766)
         
Net change in cash and cash equivalents  981,160   (95,102)
Cash and cash equivalents, beginning of period  319,546   330,557 
Cash and cash equivalents, end of period $1,300,706  $235,455 
         
Supplemental cash flow information:        
Interest paid $44,150  $- 
Income tax paid $-  $- 
         
Non-cash investing and financing activities:        
Conversions of promissory notes and accrued interest to common stock $1,205,856  $889,084 
Derivative liability on convertible promissory notes and warrants $-  $673,050 
Equipment issued in settlement of debt $-  $2,500 

(Unaudited)

See

  2023  2022 
  

For the Three Months Ended

March 31,

 
  2023  2022 
Cash Flows From Operating Activities:        
Net loss $(431,438) $(1,422,942)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Depreciation and intangible asset amortization expense  7,500   8,556 
Share-based compensation  147,094   92,517 
Provision for doubtful accounts  (1,705)  (22,168)
Provision for excess and obsolete inventory  33,638   3,676 
Loss on disposal of assets  100   5,499 
Amortization of operating lease ROU asset  26,325   25,433 
         
Changes in operating assets and liabilities:        
Accounts receivable  (57,420)  10,610 
Inventory  (126,360)  (631,269)
Prepaid expenses and other  1,018,785   (551,261)
Accounts payable and accrued liabilities  (43,124)  43,438 
Deferred revenue  (3,235,970)  2,645,579 
Operating lease liability, net  (26,662)  (14,811)
Net cash provided by (used in) operating activities  (2,689,237)  192,857 
         
Cash Flows From Investing Activities        
Purchases of property and equipment  -   (13,948)
Proceeds from the sale of property and equipment  200   - 
Net cash provided by (used in) investing activities  200   (13,948)
         
Cash Flows From Financing Activities        
Payment of dividends on series B preferred stock  -   (35,984)
Redemption of series B preferred stock  -   (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses  -   21,711,131 
Net cash provided by financing activities  -   19,695,147 
         
Net change in cash and cash equivalents  (2,689,037)  19,874,056 
Cash and cash equivalents, beginning of period  18,637,114   2,159,608 
Cash and cash equivalents, end of period $15,948,077  $22,033,664 
         
Supplemental cash flow information:        
Interest paid $-  $- 
Income taxes paid $-  $- 
         
Non-cash investing and financing activities:        
Conversion of series B preferred stock  -  $1,980,000 
Deemed dividend on series B preferred stock arising on down round  -  $439,999 
Options issued for accrued equity compensation liability $89,970  $- 

The accompanying notes to the unauditedare an integral part of these condensed consolidated financial statements.

5
 F-4

CEA Industries Inc.

Surna Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2017March 31, 2023

(in US Dollars except share numbers)

NOTE(Unaudited)

Note 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations and Significant Accounting Policies

Company:Description of Business

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. On March 26, 2014,We design, engineer and sell environmental control and other technologies for the Company acquired Safari Resource Group, Inc.Controlled Environment Agriculture (“Safari”CEA”), a Nevada corporation, whereby the Company became the sole surviving corporation after the acquisition of Safari. In July 2014, the Company acquired 100% industry. The CEA industry is one of the membership interests in Hydro Innovations, LLC, a Texas limited liability company (“Hydro”), pursuant to which Hydro became a wholly-owned subsidiaryfastest-growing sectors of the Company. The Company engineersUnited States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and manufactures innovative technologysmall fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, that address(v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the energyU.S. and resource intensive nature of indoor cultivation. The CompanyCanada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is focused onderived primarily from supplying industrial solutionsour products, services, and technologies to commercial indoor cannabis cultivation facilities. The Company’s engineering team is tasked with creating novelfacilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and resource efficient solutions,water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

Impact of the COVID-19 Pandemic on Our Business

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

The resulting effects and uncertainties from the COVID-19 pandemic, including the Company’s proprietary liquid-cooled climate control platform. The Company’s engineers continuously seekdepth and duration of the disruptions to create technologiescustomers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that allow growersthe economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the specific demandsshipment of orders can be completed.

6

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

Impact of Ukrainian Conflict

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis cultivation environment through temperature, humidity, light,space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and process control. The Company’s objectiveembargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

Inflation

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide intelligent solutionsto our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that improve the quality, controlwill permit us to adjust pricing if inflation and overall crop yieldprice increase pressures on us will impact our ability to perform our contracts and efficiency of indoor cannabis cultivation. The Company is headquartered in Boulder, Colorado. The Company does not cultivate or distribute cannabis.maintain our margins.

Financial Statement Presentation:Presentation

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

Interim Financial Statements

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the ninethree months ended September 30, 2017March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2017.2023. The balance sheet information as of December 31, 20162022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2016. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis unless otherwise noted.2022.

7
 F-5

Basis of Presentation:

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $3,553,000 for the nine months ended September 30, 2017, and had an accumulated deficit of approximately $17,889,000 as of September 30, 2017. Since inception, the Company has financed its activities principally through debt and equity financing and customer deposits. Management expects to incur additional losses and cash outflows in the foreseeable future in connection with its operating activities.

The Company’s consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

The Company is subject to a number of risks similar to those of other similar stage companies, including dependence on key individuals; successful development, marketing and branding of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks associated with research and development; dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing to fund its operations and generating a level of revenues adequate to support the Company’s cost structure. In the first quarter of 2017, the Company extinguished convertible promissory notes in the principal amount of $510,000 through the issuance of shares of its common stock (See Note 2) and raised $2,685,000 in a private placement of the Company’s common stock and attached warrants to accredited investors (see Note 6). In the third quarter of 2017, the Company extinguished notes payable in the principal amount of $537,000 through the issuance of shares of its common stock (See Note 3).

The Company will likely need to raise debt and equity financing in the future in order to continue its operations and achieve its growth targets, however, there can be no assurance that such financing will be available in sufficient amounts and on acceptable terms, when and if needed, or at all. The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors, including market demand for the Company’s products and services, the success of product development efforts, the timing of receipts for customer deposits, the management of working capital, and the continuation of normal payment terms and conditions for purchase of goods and services. The Company believes its cash balances and cash flow from operations will not be sufficient to fund its operations and growth for the next twelve months. If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then the Company will likely need to raise additional funding to continue as a going concern from investors or through other avenues.

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

Basis(in US Dollars except share numbers)

(Unaudited)

Principles of Consolidation and Reclassifications:

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly-owned subsidiary.wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profits,profit, and balances are eliminated in consolidation.

Certain reclassifications have been made to amounts in prior periods to conform to the current period presentation. All reclassifications have been applied consistently to the periods presented. The reclassifications had no impact on net loss or total assets and liabilities.

Use of Estimates:Estimates

The preparation of financial statements in conformity with GAAP requires management to makeManagement makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenuesrevenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results. Key estimates include: valuationallocation of derivative liabilities,transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities.

F-6

Warrants Issued in Connection with Financings:

The Company generally accounts for warrants issued in connection with financings as a component of equity, unless there is a possibility that the Company may have to settle the warrants in cash. For warrants issued with the deemed possibility of a cash settlement, the Company records the fair value of the issued warrants as a liability at each reporting date and records changes in the estimated fair value as a non-cash gain or loss in the condensed consolidated statements of operations. The fair values of have been determined using the Black Scholes Merton Option Pricing valuation model, or the Black-Scholes Model. The Black-Scholes Model provides for assumptions regarding volatility, call and put features and risk-free interest rates within the total period to maturity. These values are subject to a significant degree of judgment on the part of the Company.

Fair value measurements

The Company evaluates assets and liabilities, subject to fair value measurements on a recurring basis to determine the appropriate level to classify them for each reporting period. There have been no transfers between fair value measurements levels during the three months ended September 30, 2017. The carrying amounts for cash,warranty accruals, accounts receivable and accounts payable, accrued expensesinventory allowances, and other current liabilities approximate fair value duelegal contingencies.

Cash, Cash Equivalents, and Restricted Cash

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to their short-term nature.

be cash equivalents. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, usedCompany may, from time to time, have deposits in valuation techniques, are assigned a hierarchical level. The following arefinancial institutions that exceed the hierarchical levelsfederally insured amount of inputs to measure fair value:

Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities$250,000. As of March 31, 2023, the balance in active markets.
Level 2: Observable inputs that reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3: Unobservable inputs reflecting our own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The following table sets forth the Company’s assets and liabilities that were measured at fair value asaccounts was approximately $15,948,000, consequently approximately $15,698,000 of September 30, 2017 and December 31, 2016this balance was not insured by level within the fair value hierarchy:FDIC. The Company has not experienced any losses to date on depository accounts.

  As of September 30, 2017     As of December 31, 2016 
  Level I  Level
II
  Level
III
  Fair
Value
  Level I  Level
II
  Level
III
  Fair
Value
 
Financial liabilities:                                
Derivative liabilities - warrants $  $  $265,760  $265,760  $  $-  $477,814  $477,814 
Total financial assets (liabilities) $-  $-  $265,760  $265,760  $-  $-  $477,814  $477,814 

The estimated fair value of the derivative liability associated with the Company’s warrants is calculated using the Black-Scholes option pricing model.

Net Income (Loss) Per Common Share

In accordance with ASC Topic 280 – “Earnings Per Share”, the basic lossBasic income (loss) per common share is computed by dividing net loss availableincome (loss) attributable to common stockholders by the weighted averageweighted-average number of common shares outstanding.outstanding during the period without consideration of common stock equivalents. Diluted lossnet income (loss) per common share is computed similar to basic loss per common share except thatby dividing net income (loss) by the denominator is increased to include theweighted-average number of additional common shares thatoutstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would have been outstanding if the potentialbe antidilutive. Potential common shares had been issued and if the additional common shares were dilutive. As of September 30, 2017, there are approximately 19,143,050 sharesstock equivalents consist of common stock issuable upon the exercise of certain outstandingstock options and warrants and the vesting of certainrestricted stock units using the treasury method.

8

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

As of March 31, 2023, and March 31, 2022, there were respectively, 8,010,957 and 8,021,057, potentially dilutive equity instruments outstanding in respect of options outstanding to purchase Company common stock, warrants, and restricted stock units that havewere convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 as of March 31, 2023 and 7,794,154 as of March 31, 2022 related to warrants issued in connection with the sale of our shares of series B Preferred stock and common stock in prior periods. The remaining 387,185 potentially dilutive equity instruments outstanding as of March 31, 2023 and 226,903 as of March 31, 2022 related to options and restricted stock units issued to our directors and staff.

Goodwill

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been excluded fromreduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the computationfair value of dilutedthe reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

Temporary Equity

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net loss per share becauseof issuance costs, which is subsequently adjusted to redemption value (including the effect would have been anti-dilutive.amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

Revenue Recognition

9
 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

The following table sets forth the Company’s revenue by source:

Schedule of Revenue by Source

  2023  2022 
  

For the Three Months Ended

March 31,

 
  2023  2022 
Equipment and systems sales $4,396,827  $1,642,572 
Engineering and other services  124,410   86,049 
Shipping and handling  12,560   15,806 
Miscellaneous  148,776   - 
Total revenue $4,682,573  $1,744,427 

Miscellaneous revenue of $148,776 represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

Revenue Recognition Accounting Policy Summary

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

F-710
 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

Disaggregation of Revenue

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

Other Judgments and Assumptions

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

11

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

Recent (in US Dollars except share numbers)

(Unaudited)

Contract Assets and Contract Liabilities

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2023 and December 31, 2022, the Company had no contract assets.

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of March 31, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $1,102,601 and $4,338,570, respectively.

For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023. For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022.

Remaining Performance Obligations

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

12

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

As of March 31, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,869,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2023, includes booked sales orders of $379,000 from three customers that the Company does not expect to be realized until 2024, if at all. This 2024 projected revenue amount contains a booked sales order of $279,000 (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that some of its current contracts could be delayed.

The remaining performance obligations expected to be recognized through 2024 are as follows:

Schedule of Remaining Performance Obligations Expected to be Recognized

  2023  2024  Total 
Remaining performance obligations related to engineering only paid contracts $172,000  $-  $172,000 
Remaining performance obligations related to partial equipment paid contracts  1,318,000   379,000   1,697,000 
Total remaining performance obligations $1,490,000  $379,000  $1,869,000 

Product Warranty

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $188,738 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

Accounting Pronouncements:for Share-Based Compensation

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

13

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:

Schedule of Share-based Compensation Costs

  2023  2022 
  

For the Three Months Ended

March 31,

 
  2023  2022 
Share-based compensation expense included in:        
Cost of revenue $4,898  $791 
Advertising and marketing expenses  1,113   2,762 
Product development costs  3,570   - 
Selling, general and administrative expenses  137,513   88,964 
Total share-based compensation expense included in consolidated statement of operations $147,094  $92,517 

Concentrations

Three customers accounted for 39%, 28%, and 17% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022.

Three customers accounted for 68%, 20%, and 10% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

Recently Issued Accounting Pronouncements

In May 2017,March 2023, the FASB issued Accounting Standards Update (ASU) No. 2017-09,Compensation – Stock Compensation (Topic 718) – Scope of Modification Accounting,ASU 2023-01 to clarify whenrequire entities to classify and account for a change toleases with related parties on the basis of legally enforceable terms orand conditions of a share-based payment award as a modification. Under the new standard, modification is required only if the fair value, the vesting conditions, or the classification of an award as equity or liability changes as a result of the change in terms or conditions.arrangement. The amendments are effective for all entities for annualin periods beginning after December 15, 2017,2023, including interim periods within those annual periods, and will be applied prospectively. Early adoption is permitted.fiscal years. The Company is currently evaluating the effect that adoptingdoes not expect this new accounting guidance willASU to have a material impact on its consolidated results of operations, cash flows and financial position.

14

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

In January 2017,December 2022, the FASB issued ASU 2017-04,SimplifyingNo. 2022-06, which defers the Test for Goodwill Impairmentsunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2017-04”2020-04”). from December 31, 2022 to December 31, 2024. ASU 2017-04 simplifiesNo. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for goodwill impairment(or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by removing Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. ASU 2017-04 is effective for annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.reference rate reform if certain criteria are met. The Company is currently evaluating the effect that adoptingdoes not expect this new accounting guidance willASU to have a material impact on its consolidated results of operations, cash flows and financial position.

In May 2014,September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

In October 2021, the FASB issued ASU 2014-092021-08, “Business Combinations (Topic 606),Revenue805): Accounting for Contract Assets and Contract Liabilities from Contracts with CustomersCustomers”., which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The new revenue recognitionguidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard supersedes all existing revenue recognition guidance. Under thison Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

In March 2020, the FAS issued ASU an entity should recognize revenue when it transfers promised goods or servicesNo. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to customersease the potential burden in an amount that reflectsaccounting for (or recognizing the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 and its relatedeffects of) reference rate reform on financial reporting. The amendments are effective for reporting periods (including interim periods) beginning afterthe Company as of March 12, 2020 through December 31, 2017.2022. The standard may be applied retrospectivelyadoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to each prior period presentedhave a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or retrospectively withare unrelated to its financial condition, results of operations, cash flows or disclosures.

15

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

Note 2 – Leases

In February 2016 the cumulative effect recognized as ofFASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the date of adoption (“modified retrospective method”“new lease standard”). The Company currently plansadopted ASC 842 as of January 1, 2019, using the effective date method.

The new standard provides a number of optional practical expedients in transition. The Company has elected to adoptapply the standard“package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the modified retrospective method effectivenew lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 1, 2018,31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will be reflectedinclude the renewal period in its financial statementslease term.

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

Schedule of Lease Cost

  

As of

March 31, 2023

 
Operating lease right-of-use asset $436,549 
Operating lease liability, current $120,245 
Operating lease liability, long-term $348,179 
     
Remaining lease term  3.8 years 
Discount rate  3.63%

  

For the Three

Months Ended

March 31, 2023

 
Operating cash outflow from operating lease $31,069 

16

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

Future annual minimum lease payments on the New Facility Lease as of March 31, 2023 are as follows:

Schedule of Future Annual Minimum Lease Payments

Years ended December 31,   
2023 (excluding the three months ended March 31, 2023) $124,897 
2024  128,643 
2025  132,503 
2026  136,473 
Thereafter  11,654 
Total minimum lease payments  534,170 
Less imputed interest  (65,746)
Present value of minimum lease payments $468,424 

Note 3 – Inventory

Inventory consisted of the following:

Schedule of Inventory

  2023  2022 
  March 31,  December 31, 
  2023  2022 
Finished goods $410,208  $270,555 
Work in progress  154   155 
Raw materials  135,316   148,608 
Allowance for excess & obsolete inventory  (104,545)  (70,907)
Inventory, net $441,133  $348,411 

Overhead expenses of $14,101and $12,770 were included in the inventory balance as of March 31, 2023, and December 31, 2022, respectively.

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $219,000 and $1,176,000 in advance payments for inventory for the periods ended March 31, 2023, and December 31, 2022, respectively.

17

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

Note 4 – Property and Equipment

Property and equipment consisted of the following:

Schedule of Property and Equipment

  2023  2022 
  March 31,  December 31, 
  2023  2022 
Furniture and equipment $275,994  $278,389 
Vehicles  15,000   15,000 
Property and equipment, gross  290,994   293,389 
Accumulated depreciation  (230,281)  (224,876)
Property and equipment, net $60,713  $68,513 

Depreciation expense was $7,500 for the three months ended March 31, 2018. The Company is currently evaluating the effect that adopting this new accounting guidance will have on its consolidated financial statements, and is working with a consultant to assess the effects of the new standard on its internal processes, customer contracts, and future revenues.

NOTE 2 – CONVERTIBLE PROMISSORY NOTES

In the first quarter of 2017, the Company entered into note conversion and warrant amendment agreements (each an “Agreement” and together, the “Agreements”) to: (i) amend the convertible promissory notes – series 2 (“Original Notes”) to reduce the conversion price of such holder’s Original Note and simultaneously cause the conversion of the outstanding amount under such Original Note into shares of common stock of the Company (“Conversion Shares”); and (ii) reduce the exercise price of the original warrant (“Original Warrants” and together with the amended notes and the amended warrants, the “Amendments”). Each Agreement was privately negotiated so the terms vary. Pursuant to the Agreements, the Original Notes were amended to reflect a reduced conversion price per share between $0.09 and $0.22. Additionally, pursuant to the Agreements,the Original Warrants were amended to reflect a reduced exercise price per share between $0.30 and $0.35, except for one Original Warrant to reflect a reduced exercise price of $0.15 per share. The term of one Original Warrant was also extended.

Pursuant to the Agreements, in the first quarter of 2017, the Company (i) converted Original Notes with an aggregate outstanding principal amount of $510,000 and accrued interest of $134,553 in exchange for the issuance of 5,001,554 shares of the Company’s common stock, and (ii) amended Original Warrants to reduce their exercise price. In the first quarter of 2017, the Company also made payments of $314,150 to settle convertible promissory notes in the principal amount of $270,000 and accrued interest of $44,150. As of June 30, 2017, the Company had no convertible notes outstanding.

The Company has accounted for the Agreements as debt extinguishment where by the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt was recognized as a loss during the first quarter of 2017. The following details the calculation of the loss on extinguishment of the notes payable – series 2 in the first quarter of 2017:

F-8

Carrying amount of debt    
Principal converted $510,000 
Accrued interest converted  134,553 
Unamortized debt discount  (5,398)
Total carrying amount of debt  639,155 
Reacquisition price of debt    
Fair value of shares of common stock issued  995,155 
Warrant modification value  59,000 
Total reacquisition price of debt  1,054,155 
Loss on extinguishment of debt $(415,000)

NOTE 3 – PROMISSORY NOTES

On February 9, 2017, the Company entered into a securities purchase agreement with two accredited investors pursuant to which the Company issued promissory notes in the aggregate original principal amount of $537,500. In addition, each investor received 125,000 shares, an aggregate of 250,000 shares, of the Company’s common stock. The notes were unsecured, had an interest rate of 6%, per annum and were originally due and payable, with all accrued interest, on November 9, 2017. The total proceeds were approximately $500,000 with an original issue discount of approximately $37,500. The Company allocated the cash proceeds amount between the debt and shares issued on a relative fair value basis. Based on relative fair value, the Company allocated approximately $461,000 and $39,000 to the promissory notes and the shares of common stock, respectively. The original issue discount of $37,500 and fair value of the shares issued of $39,000 were amortized and expensed over the life of the loans.2023. For the three and nine months ended September 30, 2017,March 31, 2023, $1,214 was allocated to cost of sales, $304 was allocated to inventory with the amortization expense was approximately $11,000remainder recorded as selling, general, and approximately $50,000, respectively. In the event of a default under the termsadministrative expense.

Note 5 – Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the promissory notes, the interest rate automatically increases to 18% per annum, until such time as the default event is cured. The eventsfollowing:

Schedule of default included suspension from trading of the Company’s common stock, failure to pay principal or interest when due, commencement of bankruptcy or insolvency proceedings or a change of control.

On August 8, 2017, the Company executed an amendment (the “Amendment”) with the holders of the promissory notes, each in the original principal amount of $268,750. The Amendment provides for each of the holder’s notes to convert its principal into 2,800,000 shares, or 5,600,000 shares in the aggregate, of the Company’s common stock, at a price per share of approximately $0.096. The Company’s closing share price on August 7, 2017 was $0.135. In connection with this Amendment, the holders also agreed to surrender to the Company the portion of the promissory notes representing the accrued interest as the consideration for this Amendment, which approximates $16,900 in total. The transactions contemplated by the Amendment closed on August 22, 2017.

The Company has accounted for the Amendment as debt extinguishment whereby the difference between the reacquisition price of the debtAccounts Payable and the net carrying amount of the extinguished debt was recognized as a loss during the third quarter of 2017. The following details the calculation of the loss on extinguishment of the notes payable in the third quarter of 2017:Accrued Liabilities

Carrying amount of debt    
Principal converted $537,500 
Accrued interest converted  15,904 
Unamortized debt discount  (25,832)
Total carrying amount of debt  527,572 
Reacquisition price of debt    
Fair value of shares of common stock issued  756,000 
Loss on extinguishment of debt $(228,428)

F-9

  2023  2022 
  March 31,  December 31, 
  2023  2022 
Accounts payable $714,586  $311,162 
Sales commissions payable  24,468   25,951 
Accrued payroll liabilities  167,697   465,094 
Product warranty accrual  188,738   180,457 
Other accrued expenses  68,645   224,594 
Total $1,164,134  $1,207,258 

Note 6 – Commitments and Contingencies

NOTE 4 – COMMITMENTS AND CONTINGENCIES

Litigation

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

Internal Revenue Service PenaltiesLeases

The Company has been penalizeda lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

Other Commitments

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Internal Revenue Service for failureCompany, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, file its Foreign Form 5471, Information Returnamong other things, indemnify them against certain liabilities that may arise by reason of U.S. Persons With Respect To Certain Foreign Corporations, for the years 2009 through 2014 on a timely basis. The penalties approximate $115,000. The Company’s request that the penalties be abated was initially denied by the Internal Revenue Service.their status or service as directors, officers, or employees. The Company is appealingmaintains director and believesofficer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

18

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

Note 7 – Stockholders’ Equity (Deficit)

As of March 31, 2023, the likelihoodCompany had 200,000,000 shares of abatement is high basedcommon stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

As of March 31, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

Directors Remuneration

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on reasonable cause. However, there can be no assurancewhich the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

On January 17, 2022, the Company issued an RSU grant of any abatement until3,367 shares of common stock under the Internal Revenue Service acts upon2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the appeal.

Stock Optionsremaining 1,683 shares of Former CEO

In March 2017, a former CEOcommon stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

On January 3, 2023, the Company requestedissued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to exerciseeach of its four independent directors. The RSUs were granted as an optionequity retention award pursuant to purchase 3,000,000the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock at an exercise pricewere issued in settlement of $.00024 per share. The stock option expired in March 2017.The Company’sthe RSUs.

Revised Compensation Plan

On January 17, 2022, the Board of Directors (the “Board”) has not approvedrevised the requestpreviously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the issuancethen current independent directors and for independent directors elected or appointed after the Effective Date.

The plan is divided into two phases: from the Effective Date of the common stock underPlan until February 9, 2022, the stock option.

New Building Lease

On June 27, 2017, the Company executed a lease, to be effective September 29, 2017, for its manufacturing and office space. The term of the lease commenced September 29, 2017 and continues through August 31, 2022. The Company will occupy its current space at a rate of $12,967 per month until January 1, 2018. On January 2, 2018, the space will be expanded and the monthly rental rate will increase to $18,979 until August 31, 2018. Beginning September 1, 2018, the monthly rent will increase by 3% each year through the end of the lease. Pursuantday prior to the lease, the Company made a security deposit of $51,000 on July 31, 2017 and received a $100,000 allowance for leasehold improvements. No leasehold improvements have been made as of September 30, 2017.

The following is a schedule by years of the minimum future lease payments on the building lease as of September 30, 2017.

Year ending December 31:   
2017 $38,901 
2018  230,026 
2019  236,926 
2020  244,034 
2021  251,355 
Later years  170,888 
Total future minimum lease payments $1,172,130 

F-10

NOTE 5 – RELATED PARTY TRANSACTIONS

Keen Consulting Agreement

On May 10, 2017, the Board approved a three-year consulting agreement between the Company and Stephen Keen, a principal shareholderlisting of the Company securities on Nasdaq. (“Pre-uplist”) and a former officer and director. Underfrom February 10, 2022, the consulting agreement, Mr. Keen will provide certain consulting services to the Company including research and development, new product design and innovations, existing product enhancements and improvements, and other technology advancements with respect to the Company’s business and products in exchange for an annual consulting fee of $30,000.uplist date forward (“Post-uplist”).

Pre-uplist phase: The consulting agreement also includes certain activity restrictions which prohibit Mr. Keen from competing with the Company. In connection with the execution of this consulting agreement, Mr. Keen resigned as a director of the Company on May 10, 2017. Mr. Keen’s employment with the Company ceased as of April 28, 2017. Pursuant to the terms of this agreement, the Company paid Mr. Keen $7,500 and $12,500 for the three and nine months ended September 30, 2017, respectively.

Sterling Pharms Equipment Agreement

On May 10, 2017, the Board approved a three-year equipment, demonstration and product testing agreement between the Company and Sterling Pharms, LLC (“Sterling”), an entity controlled by Mr. Keen, which operates a Colorado-regulated cannabis cultivation facility currently under construction. Under this agreement, the Company has agreed to provide to Sterling certain lighting, environmental control, and air sanitation equipment for use at the Sterling facility in exchange for a quarterly fee of $16,500. Also, under this agreement, Sterling has agreed to allow the Company and its existing and prospective customers to have access to the Sterling facility for demonstration tours in a working environment, which the Company believes will assist it in the sale of its products. Sterling has also agreed to monitor, test and evaluate the Company’s products installed at the Sterling facility and to collect data and provide feedback to the Company on the energy and operational efficiency and efficacy of the installed products, which the Company intends to use to improve, enhance and develop new or additional product features, innovations and technologies. In consideration for access to the Sterling facility to conduct demonstration tours and for the product testing and data to be provided by Sterling, the Company will pay Sterling a quarterly fee of $12,000.

As of September 30, 2017, Sterling Pharms had accepted substantially all the equipment under the agreement, but is in the process of completing the installation of the equipment. Pursuant to the terms of this agreement, the respective payments will begin upon the delivery and installation of the equipment.

In September 2017, the Company received a deposit from Sterling of $78,310 to purchase equipment unrelated to the lease. The Company purchased on behalf of Sterling additional equipment of $23,520 which is included in Other Receivables.

Independent Director Compensation Plan

On August 8, 2017, the Board approved a compensation plan for the Company’s independent directors effective for the election or appointment of independent directors on or after May 31, 2017. Under this compensation plan, the Company will pay the independent directors an annual cash fee of $60,000,$15,000, payable quarterly in advance on the first business day of each quarter, coveringas consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director participated,is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as a directordirectors (other than services as the Chairman of the Board, and lead independent director and the Chairman of the Company’s Audit Committee)Committee, and the Committee Chairman).

19

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The annual fee is paid 50% in cash and 50% in sharesaggregate value of the Company’s common stock,RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of issuance.

The Company pays the Chairmangrant. Vesting of the BoardRSUs was as follows: (i) 50% at the time of grant, and lead(ii) 50% on the first anniversary of the grant date.

In addition, on the first business day of January each year, each independent director will also receive an additional annual feeequity retention award in the form of $15,000, payable quarterly in advance. RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

The Company pays the Audit Committee Chairman an additional annual fee of $15,000,$10,000, payable quarterly in advance, for his services as the Audit Committee Chairman.

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

There is no additional compensation paid to members of any committee of the Audit Committee.

F-11

At the time of initial election or appointment, each director also receives an equity retention award in the form of non-qualified stock options to purchase shares of common stock, shares of common stock, or a combination thereof.

Employment Agreement with Current ChiefBoard. Interested (i.e. Executive Officer

On September 6, 2017,directors) serving on the Board approveddo not receive compensation for their Board service.

Post-uplist phase: The Company will pay its independent directors an employment agreement between the Company and its current Chief Executive Officer (“the CEO”)annual cash fee of $25,000, which included the grant of certain restricted stock units.

The initial term of the employment agreement commenced on August 17, 2017, the date of the CEO’s appointment, and will continue until December 31, 2019. However, the Company and the CEO may terminate the employment agreement, at any time, with or without cause, by providing the other party with 30-days’ prior written notice. In the event the CEO’s employment is terminated by the Company during the initial term without cause, the CEO will be entitled to receive his base salary for an additional 30 days. Following the initial term, the Company and the CEO may extend the employment agreement for additional one-year terms by mutual written agreement.

The CEO will receive an annualized base salary of $180,000. Beginning December 31, 2017 and for each six-month period through December 31, 2019, the CEO will also be eligible to receive a special bonus of 1,000,000 shares of the Company’s common stock, provided the Board has determined,payable quarterly in its sole discretion, that the CEO’s performance has been average or better for such special bonus period.

The Board also granted the CEO a total of 3,000,000 restricted stock units, which vest based on the CEO’s continued service and subject to the following performance thresholds: (i) 1,500,000 restricted stock units will vest on March 31, 2019 if the Company achieves 2018 revenue of $18,000,000, and (iii) 1,500,000 restricted stock units will vest on March 31, 2020 if the Company achieves 2019 revenue of $25,000,000.

In consideration of the grant of the restricted stock units and the eligibility for the special bonus, the CEO agreed to terminate and cancel the non-qualified stock options to purchase 900,000 shares of the Company’s common stock, which were granted to him as an equity retention award in connection with his appointment to the Board on August 8, 2017.

In the event of a change of control involving the Company, (i) any restricted stock units not already vested will become vested (other than those restricted stock units that were previously forfeited due to failure to meet the performance threshold), and (ii) any remaining special bonuses related to any bonus period ending after the date of the change of control will become due and payable, provided the CEO continues to provide services to the Company on the date immediately preceding the date of the change of control.

On August 8, 2017, the CEO was awarded 600,000 shares of the Company’s common stock in consideration of services rendered to the Company prior to his appointment as a director. These shares were fully vested at the time of the award.

Resignation of Former Chief Executive Officer

On August 17, 2017, the Company’s then current Chief Executive Officer (the “Previous CEO”) notified the Board of his resignation, including his resignation as a director, effective August 17, 2017.

On August 17, 2017, the Company and the Previous CEO entered into an employment agreement pursuant to which the Previous CEO will continue his employment as the Company���s Vice President Business Development – West Coast, a non-executive officer position. The Previous CEO will focus his efforts and use his industry knowledge to assist the Company in developing the significant market opportunities resulting from the recent legalization of cannabis for recreational use in the State of California. The initial term of the employment agreement commences on August 17, 2017 and continues until March 31, 2018. The employment agreement may be extended beyond the initial term upon the mutual agreement of the Company and the Previous CEO.

On August 17, 2017, the Board also granted the Previous CEO a total of 9,000,000 restricted stock units, which vest in twelve (12) equal installments (750,000 restricted stock units per installment) commencing on the first business day of January 2018 and continuingadvance on the first business day of each quarter. All other terms remain the same.

Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

Employee directors do not receive separate fees for their services as directors.

Reverse Stock Split

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

As a result of this reverse stock split, the number of the next eleven (11) calendar months, provided thatCompany’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Previous CEO is employed by the Company on such vesting date or, if the initial term under the employment agreement has expired, the Previous CEO has not materially breached any non-competition, non-solicitation and other post-termination of employment obligations.Reverse Split for all periods presented.

20
 F-12

CEA Industries Inc.

NOTE 6 – SHAREHOLDERS’ EQUITYNotes to Condensed Consolidated Financial Statements

March 31, 2023

Private Placement(in US Dollars except share numbers)

(Unaudited)

Change in Authorized Share Capital

In March 2017,connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company entered intoto 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

Equity Raise

On February 10, 2022, the Company signed a Securities Purchase Agreement (the “Agreement”) with certain accredited investors (the “Investors”).firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company issued an aggregate of 16,781,250 investment units (the “Units”), for aggregate grossreceived net proceeds of $2,685,000. Each Unit consistedapproximately $22 million for the sale of5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of the Company’s common stock and one warrant for the purchase of one share of the Company’s common stock; however, one investor declined receipt of the warrant to purchase 468,750 shares of the Company’s common stock.

Pursuant to each of the warrants, the holder thereof may, subject to the terms of the warrant, at any time on or after six months after the date of the warrant and on or prior to the close of business on the date that is the third anniversary of the date of the warrant, purchase up to the number of shares of the Company’s common stock as set forth in the respective warrant. The exercise price per share of the common stock under each warrant is $0.26, subject to adjustment as provided in the warrant. Each warrant is callable at the Company’s option commencing six months from the date of the warrant, provided the Company’s common stock trades at a volume weighted average price (“VWAP”) of $0.42 or greater (subject to adjustment) for five consecutive trading days (the “Call Condition”). Commencing at any time after the date on which the Call Condition is satisfied, the Company has the right, upon 30 days’ notice to the holder given not later than 30 trading days after the date on which the Call Condition is satisfied, to redeem the number of warrant shares specified in the applicable Call Condition at a price of $0.01 per warrant share, subject to the terms of the warrant.

Equity Issued as Compensation for Services

Warrants Issued to Former Director

On May 31, 2017, in connection with the resignation of a former director, the Company agreed to issue the former director three individual warrants to purchase: (i) 900,000 shares (“Warrant 1”), (ii) 460,525 shares (“Warrant 2”), and (iii) 460,525 shares (“Warrant 3”) (collectively, the “Warrants”) of the Company’s common stock for a period of five years. Warrant 1 was granted on June 20, 2017, is fully vested, and can be exercised beginning December 21, 2017years, exercisable immediately, at an exercise price of $0.114 per$5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share with the option for a cashless exercise. Warrants 2 and 3 were granted on June 20, 2017, are fully vested, and can be exercised beginning December 21, 2017of common stock at an exercise price of $0.0005 per share with$5.1625, during the option for a cashless exercise. The Company recorded approximately $207,000 of compensation expense for the fair value the Warrantsperiod commencing August 9, 2022, and expiring on the grant date. The fair value of the Warrants at the date of grant was determined using the Black-Scholes Option Pricing Model. The assumptions used in the Black-Scholes Option Pricing Model were term of the Warrants of 5 years, volatility rate of 119.96%, quarterly dividends 0%, and a risk-free interest rate of 1.77%February 10, 2027.

Warrants Issued to Investment BankWarrant Exercise

On June 18, 2017, for services rendered21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion of the Original Notes, the Company issued to an investment bank or its designees a warrant (“Banker Warrant”) to purchase, at an exercise price $0.35 per share, 500,000 shares of the Company’s common stock for a period of three years. The Banker Warrants were fully vested on the date of issuance and may be exercised beginning December 20, 2017. The Company recorded approximately $55,000 of expense for the fair value the Banker Warrant on the date of issuance. The fair value of the Banker Warrants at date of issuance was determined using the Black-Scholes Option Pricing Model. The assumptions used in the Black-Scholes Option Pricing Model were term of the Banker Warrant of 3 years, volatility rate of 120.02%, rate of quarterly dividends 0% and a risk-free interest rate of 1.52%.warrants.

F-13

Common Shares Issued to EmployeeNote 8 – Equity Incentive Plans

During the first quarter of 2017 the Company issued to an employee 40,000 shares of common stock which were valued at approximately $9,000 on the date of issuance.

Common Shares Issued to Director

On March 14, 2017, the Company issued to its Chairman of the Board (the “Chairman”) 700,000 shares of common stock as an equity retention award. These shares were valued, using the closing price for the Company’s common stock, as of the date of ratification for total value of $122,000, which was expensed as compensation.

2014 Stock OwnershipEquity Incentive Plan

As of December 31, 2016, the Company had non-qualified stock options to purchase 6,177,600 shares of the Company’s common stock, with an exercise price of $0.00024, outstanding under the 2014 Stock Ownership Plan of Safari Resource Group, Inc. (the “2014 Stock Plan”). Upon the adoption ofUnder the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), there will be no further awards under the 2014 Stock Plan.

In March 2017, in a private transaction, certain principal shareholders of the Company, assigned to the Previous CEO, non-qualified stock options to purchase 3,088,800 shares of the Company’s common stock outstanding under the 2014 Stock Plan. The principal shareholders informed the Company that they agreed to assign these options as an incentive (i) for the Previous CEO to complete the negotiations with the Company’s convertible noteholders to convert their notes into shares of the Company’s common stock, and (ii) for the Previous CEO to complete a private placement of the Company’s common stock. The Previous CEO thereupon delivered a purported notice of exercise of the options to the Company just prior to the expiration of the options. The Company erroneously reported in its Form 10-K for the year ended December 31, 2016 that the common stock underlying these options had been issued during the three months ended March 31, 2017. Prior to the Company’s acceptance of the notice of exercise and issuances of these shares in response thereto, in May 2017, the Previous CEO and the principal shareholders entered into a rescission agreement to nullify the March 2017 assignment transaction. Pursuant to their terms, the options have expired.

In March 2017, a former CEO of the Company, holding non-qualified options to 3,088,800 shares of the Company’s common stock outstanding under the 2014 Stock Plan, requested to exercise options with respect to 3,000,000 shares at an exercise price of $.00024 per share.The Board has not approved the request for the issuance of the common stock underlying these exercised options. All of these options expired in March 2017.

As of September 30, 2017, there are no options outstanding under the 2014 Stock Plan.

2017 Equity Incentive Plan

On August 1, 2017, the Board adopted and approved the 2017 Equity Plan in order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants, and other persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under the 2017 Equity Plan, the Boardof Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 50,000,000333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. AsIf any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of September 30, 2017,such shares, the Company has granted,shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

During the three months ended March 31, 2023, no shares or options were issued, or cancelled under the 2017 Plan.

As of March 31, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 147,177 options remain outstanding, and 22,464 shares remain available for future equity awards.

21

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

2021 Equity Incentive Plan

On March 22, 2021, the formBoard approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares for services rendered byof common stock that may be issued pursuant to this Plan.

During the three months ended March 31, 2023, the Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

During the three months ended March 31, 2023,138,491 non-qualified stock options were issued to five employees and consultants,three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

As of March 31, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 183,615 non-qualified stock options, and RSUs.40,816 incentive stock options remain outstanding, and 309,668 shares remain available for future equity awards.

Equity-based compensation costs are classifiedThere was $45,919 in the Company’s consolidated financial statements in the same manner as if such compensation was paid in cash. The following is a summary of equity-based compensation costs under the 2017 Equity Plan included in the Company’s consolidated statements of operations for the three and nine months ended September 30, 2017:

F-14

  Three months  Nine months 
Equity-based compensation expense included in:        
Cost of revenue $38,104  $38,104 
Advertising and marketing expenses  7,259   7,259 
Product development costs  2,640   2,640 
Selling, general and administrative expenses  578,151   877,856 
Total equity-based compensation expense included in consolidated statement of operations $626,154  $925,859 

Equity-based compensation expense is reduced for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

The total unrecognized compensation expense for unvested equity-based compensation awardsnon-qualified stock options, and incentive stock options at September 30, 2017, was $1,304,660,March 31, 2023 which will be recognized over approximately 2.252 years. This unrecognized compensation expense does not include

Non-Qualified and Incentive Stock Options

A summary of the potential futurenon-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2023, are presented in the table below:

Schedule of Stock Option Activity

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
             
Outstanding, December 31, 2022  192,073  $8.94   7.6  $            - 
Granted  138,489  $0.90   8.4  $- 
Exercised  -  $-   -  $- 
Forfeited  (500) $6.10   8.9  $- 
Expired  -  $-   -  $- 
Outstanding, March 31, 2023  330,062  $5.57   7.6  $- 
Exercisable, March 31, 2023  304,972  $5.59   8.2  $- 

22

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2023, are presented in the table below:

Summary of Non-vested Non-qualified Stock Option Activity

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

  

Grant-Date

Fair Value

 
            
Nonvested, December 31, 2022  43,846  $5.65  $  -  $247,730 
Granted  138,489  $0.88  $-  $122,346 
Vested  (156,912) $1.49  $-  $(234,296)
Forfeited  (333) $6.67  $-  $(2,225)
Expired  -  $-  $-  $- 
Nonvested, March 31, 2023  25,090  $4.98  $-  $133,555 

For the three months ended March 31, 2023 and March 31, 2022, the Company recorded $45,778 and $32,939 as compensation expense related to equity awards which are subjectvested options issued to vesting based on certain revenueemployees and bookings thresholds for 2017, 2018 and 2019 being satisfied (the “Performance-based Awards”). Asconsultants, net of September 30, 2017 and the grant date, the Company has determined that the likelihood of performance levels being obtained is remote.forfeitures, respectively.

Restricted Stock Awards

On August 8, 2017, the CEO was awarded 600,000 shares of restricted stock under the 2017 Equity Plan in consideration of services rendered to the Company prior to his appointment as a director. These restricted shares were fully vested at the time of the award and the value attributable to these shares, which were issued in August 2017, was $84,000 as calculated using the fair value of the Company’s common stock on August 7, 2017. See Note 5 – Related Party Transactions – Employment Agreement with Current Chief Executive Officer.

On August 8, 2017, the Company awarded 111,113 restricted shares under the 2017 Equity Plan to independent directors in lieu of the payment of cash fees earned during the second quarter of 2017. These restricted shares were fully vested at the time of the award. The value attributable to these shares, which were issued in August 2017, was $15,000 as calculated using the fair value of the Company’s common stock on August 7, 2017. As of September 30, 2017, the independent directors are owed cash fees of $15,000 which will be paid in the form of fully vested restricted shares in November 2017.

On August 8, 2017, the Company awarded 260,778 restricted shares under the 2017 Equity Plan to a consultant who provided corporate and financial services to the Company. These restricted shares were awarded in lieu of cash fees earned for the April, May, June and July 2017 and were fully vested at the time of the award. The value attributable to these shares, which were issued in August 2017, was $35,000 as calculated using the fair value of the Company’s common stock on August 7, 2017. As of September 30, 2017, the consultant is owed cash fees of $15,000 which will be paid in the form of fully vested restricted shares in November 2017.

On September 6, 2017, the Company awarded 1,200,000 restricted shares under the 2017 Equity Plan to an employee as compensation. These restricted shares were fully vested at the time of the award. The value attributable to these shares, which were issued in October 2017, was $134,280 as calculated using the fair value of the Company’s common stock on September 6, 2017. These shares are reflected as shares to be issued in the Company’s Statement of Changes in Shareholders’ Equity (Deficit).

F-15

Non-Qualified Stock Options

On August 8, 2017, the Board granted to certain independent directors non-qualified stock options, under the 2017 Equity Plan, to purchase a total of 1,800,000 shares of the Company’s common stock at an exercise price of $0.135 per share for a period of ten years. These options vest 50% on date of grant and the remaining 50% on March 1, 2018, provided they are still serving as a director on such date. On August 17, 2017, one of these independent directors was appointed the CEO and, in consideration of the grant of the restricted stock units and the eligibility for the special bonus, the CEO agreed to terminate and cancel the non-qualified stock options to purchase 900,000 shares of the Company’s common stock previously granted to him.

During the third quarter of 2017, the Board granted to certain employees non-qualified stock options, under the 2017 Equity Plan, to purchase a total of 12,355,000 shares of the Company’s common stock at an exercise price equal to the closing market price of the Company’s common stock on the day before the grant. The terms of the options are summarized as follows:

(a)Non-qualified stock options to purchase 1,805,000 shares at an exercise price of $0.135 per share granted to certain employees on August 8, 2017, which vest based on the employee’s continued service over 2.75 years, as follows: (i) 661,672 options will vest if the employee remains employed at various dates during 2017, (ii) 571,665 options will vest if the employee remains employed at various dates during 2018, and (iii) 571,663 options will vest if the employee remains employed at various dates during 2019, and have a term of 10 years. As of September 30, 2017, non-qualified stock options to purchase 60,000 shares have expired.
(b)Non-qualified stock options to purchase 1,300,000 shares at an exercise price of $0.121 per share granted to a former employee on August 17, 2017, which were fully vested on the grant date and have a term of three years.
(c)Non-qualified stock options to purchase 1,200,000 shares at an exercise price of $0.135 per share granted to certain employees on August 8, 2017, which vest based on the employee’s continued service and subject to the following performance thresholds: (i) 400,000 options will vest if the Company achieves $8,000,000 and $10,000,000 of revenue and new bookings, respectively, for the year end December 31, 2017, (ii) 400,000 options will vest if the Company achieves 2018 revenue of $18,000,000, and (iii) 400,000 options will vest if the Company achieves 2019 revenue of $25,000,000.
(d)Non-qualified stock options to purchase 4,050,000 shares at an exercise price of $0.121 per share granted to certain employees on August 17, 2017, which vest based on the employee’s continued service and subject to the following performance thresholds: (i) 800,000 options will vest if the Company achieves $8,000,000 and $10,000,000 of revenue and new bookings, respectively, for the year end December 31, 2017, (ii) 1,300,000 options will vest if the Company achieves 2018 revenue of $18,000,000, and (iii) 1,950,000 options will vest if the Company achieves 2019 revenue of $25,000,000.
(e)Non-qualified stock options to purchase 4,000,000 shares at an exercise price of $0.112 per share granted to an employee on September 9, 2017, which vest based on the employee’s continued service and subject to the following performance thresholds: (i) 750,000 options will vest if the Company achieves $8,000,000 and $10,000,000 of revenue and new bookings, respectively, for the year end December 31, 2017, (ii) 1,250,000 options will vest if the Company achieves 2018 revenue of $18,000,000, and (iii) 2,000,000 options will vest if the Company achieves 2019 revenue of $25,000,000.

The Company uses theBlack-Scholes Option Pricing Model to determine the fair value of options granted. Option-pricing models require the input of highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions are based on the historical volatility of the Company’s common stock over periods that are similar to the expected terms of grants and other relevant factors. The Company derives the expected term based on historical experience and other relevant factors concerning expected employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant. The Company has never paid any cash dividends on its common stock and the Company has no intention to pay a dividend at this time; therefore, the Company assumes that no dividends will be paid over the expected terms of option awards.

F-16

The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. The valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility 117.13% - 120.6%; expected term in years 5.0 - 7.5 and risk free interest rate 1.71% - 2.07%

A summary of the non-qualified stock options granted to employeesdirectors under the2017 Equity Planas of September 30, 2017, and changesthe 2021 Equity Plan, during the ninethree months then ended March 31, 2023, are presented in the table below:

Schedule of Stock Option Activity

  Number of Options  Weighted Average Exercise Price  Weighted Average Remaining Contractual Term  Aggregate Intrinsic Value ($000) 
             
Outstanding as of December 31, 2016  -  $-   -   - 
Granted  12,355,000   0.121   9.9   - 
Exercised  -   -   -   - 
Forfeited  -   -   -   - 
Expired  (60,000)  0.135   9.9   - 
Outstanding as of September 30, 2017  12,295,000   0.121   9.9   - 
Expected to vest as of September 30, 2017  3,045,000   0.129   9.9   - 
  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
             
Outstanding, December 31, 2022  57,122  $9.44   6.0  $      - 
Granted  -   -   0.0  $- 
Exercised  -   -   -  $- 
Forfeited/Cancelled  -   -   -  $- 
Expired  -   -   -  $- 
Outstanding, March 31, 2023  57,122  $9.44   5.7  $- 
Exercisable, March 31, 2023  57,122  $9.44   5.7  $- 

As of September 30, 2017, of the options to purchase 12,295,000 shares outstanding, options to purchase 9,250,000 shares are performance-based and the Company has determined that the likelihood of performance levels being obtained is remote as of the date of grant and September 30, 2017. Based on the low level of obtaining the performance level, the fair value of these performance-based options was negligible as of the grant date and September 30, 2017.

A summary of theThere were no non-vested, non-qualified stock options granted to the directors under the2017 Equity Planas of September 30, 2017, and changes during the nine months then ended, are presented in the table below:

  Number of Options  Weighted Average Exercise Price  Weighted Average Remaining Contractual Term  Aggregate Intrinsic Value ($000) 
             
Outstanding as of December 31, 2016  -  $-   -   - 
Granted  1,800,000   0.135   9.9   - 
Exercised  -   -   -   - 
Forfeited/Cancelled  (900,000)  0.135   9.9   - 
Expired  -   -   -   - 
Outstanding and expected to vest as of September 30, 2017  900,000   0.135   9.9   - 

F-17

The total fair value of vested options issued to employees and directors and recorded as compensation expense was $303,000 and $371,000 for the three and nine months ended September 30, 2017, respectively. Compensation expense for the nine months ended September 30, 2017 includes $68,000 for cancelled options.

Restricted Stock Units

On August 8, 2017, the Company awarded 700,000 restricted stock units to the Chairman based on the retention agreement between the Company and the Chairman entered into in March 2017 prior to his appointment. These restricted stock units will vest on March 1, 2018, provided he remains a director on such date, and will be settled by the issuance of one share of common stock for each vested restricted stock unit.

On June 12, 2017, the Company entered into a consulting agreement for a sales and business development services. The consulting term ended on September 1, 2017. The consultant was compensated with an award of 200,000 restricted stock units, which vested on the following dates: 66,667 units on July 7, 2017, 66,667 units on August 4, 2017 and 66,666 units on September 1, 2017. Each vested restricted stock unit will be settled by the issuance of one share of common stock. The Company will account for these restricted stock units using the graded vesting method with the total value of the restricted stock units calculated on the date the shares of common stock are issued to the consultant. For accounting purposes, the restricted stock units will be revalued at each reporting date with the final value being the date the shares of common stock are issued to the consultant. The Company recorded an expense of $17,000 and $21,000 for the three and nine months ended September 30, 2017, respectively. The Company issued 200,000 shares of common stock to settle the vested restricted stock units on October 3, 2017 which are reflected as shares to be issued in the Company’s Statement of Changes in Shareholders’ Equity (Deficit).

During the third quarter of 2017, the Company also issued 12,700,000 restricted stock units to employees as follows:

(a)On August 17, 2017, the Company granted 700,000 restricted stock units to certain employees which vest at various times during the first quarter of 2018, provided the employee remains employed as of the vesting date.
(b)On August 17, 2017, the Company granted to the Previous CEO 9,000,000 restricted stock units, which vest in 12 equal installments (750,000 restricted stock units per installment) commencing on the first business day of January 2018 and continuing on the first business day of each of the next 11 calendar months, provided that the Previous CEO is employed by the Company on such vesting date or, if the initial term under the employment agreement has expired, the Previous CEO has not materially breached any non-competition, non-solicitation and other post-termination of his employment obligations.
(c)On September 6, 2017, the Company granted 3,000,000 restricted stock units to the CEO, which vest based on the CEO’s continued service and subject to the following performance thresholds: (i) 1,500,000 restricted stock units will vest if the Company achieves 2018 revenue of $18,000,000, and (ii) 1,500,000 restricted stock units will vest if the Company achieves 2019 revenue of $25,000,000.

All of the foregoing restricted stock unit awards will be settled by the issuance of one share of common stock for each vested restricted stock unit.

A summary of the restricted stock units awarded to employees, directors and consultants under the 2017 Equity Plan as September 30, 2017 and changes during the period then2021 Equity Plan, for the three months ended are presented in the table below:March 31, 2023.

 Number of Units  Weighted Average Grant-Date Fair Value 
        
Unvested as of December 31, 2016  -  $- 
Granted  13,600,000   0.122 
Vested  (1,828,000)  0.132 
Forfeited  -   - 
Unvested as of September 30, 2017  11,772,000   0.121 
Expected to vest as of September 30, 2017  8,772,000  $0.123 

23
 F-18

As of September 30, 2017, of the unvested 11,772,000 restricted stock units, 3,000,000 restricted stock units are performance-based and the Company has determined that the likelihood of performance levels being obtained is remote as of the date of grant and September 30, 2017. Based on the low level of obtaining the performance level, the fair value of these performance-based restricted stock units was negligible as of the grant date and September 30, 2017.CEA Industries Inc.

.

The total fair value of the vested restricted stock units issued to employees, directors and consultants and recorded as compensation expense was $214,000 and $239,000 for the three and nine months ended September 30, 2017, respectively.

NOTE 7 – SUBSEQUENT EVENTS

Unless disclosed elsewhere within the Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

During the following significant subsequent events occurring after September 30, 2017 are discussed below.three months ended March 31, 2023 and March 31, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

EquityRestricted Stock Units

In October 2017,Effective January 3, 2023, the Company issued 1,400,000 sharesa total of 119,032 restricted stock units (RSUs) under the Company’s common stock, which were classified as shares2021 Equity Plan to beits four independent directors. These RSUs vested upon grant.

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued as of September 30, 2017, consisting of 1,200,000 restricted shares issued as compensationon January 17, 2022 to an employeetwo new directors and 200,000 restricted units issued to a consultant as compensation which were settledthat vested after 12 months by the issuance of 200,000 shares.shares of common stock

On October 10, 2017,During the Board granted non-qualified stock options, underthree months ended March 31, 2023 and March 31, 2022, the 2017 Equity Plan,Company recorded $101,316 and $29,923, respectively, as compensation expense related to certain employeesvested RSUs issued to directors.

Schedule of Restricted Stock Units Activity

  

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
         
Outstanding, December 31, 2022  3,366  $7.42  $- 
Granted  119,032  $0.84  $- 
Vested and settled with share issuance  (122,398) $1.02  $- 
Forfeited/canceled  -  $-  $- 
Outstanding, March 31, 2023  -  $-  $- 

Note 9 - Warrants

The following table summarizes information with respect to outstanding warrants to purchase 175,000 sharescommon stock during the three months ended March 31, 2023:

Schedule of Outstanding Warrants to Purchase Common Stock

        Weighted  Weighted    
        Average  Average  Aggregate 
  Warrants  Exercise  Remaining Life  Intrinsic 
  Outstanding  Exercisable  Price  In Months  Value 
                
Outstanding at December 31, 2022  7,623,772   7,623,772  $5.14   49        - 
                     
Granted  -   -   -   -   - 
                     
Exercised  -   -   -   -   - 
                     
Expired  -   -   -   -   - 
                     
Outstanding at March 31, 2023  7,623,772   7,623,772  $5.14   46   - 

The following table summarizes information about warrants outstanding at an exercise priceMarch 31, 2023:

Schedule of $0.105 perWarrants Outstanding

   Warrants  Weighted Average 
Exercise price  Outstanding  Exercisable  Months Outstanding 
           
 9.45   192,982   192,982   18 
               
 10.40   34,737   34,737   19 
               
 5.00   7,105,496   7,105,496   47 
               
 5.16   290,557   290,557   47 
               
     7,623,772   7,623,772   46 

24

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

Note 10 – Income Taxes

As of March 31, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $26,380,000, of which vest over the next 2.75 years.

On October 10, 2017, the Board awarded an employee 200,000 restricted stock units, under the 2017 Equity Plan, which vest$11,196,000 will expire, if not utilized, in the second quarteryears 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

In addition, pursuant to Section 382 of 2018.

On November 7, 2017, the Board awarded an employee 200,000 restricted stock units, underInternal Revenue Code of 1986, as amended, use of the 2017 Equity Plan, which vestCompany’s NOLs carryforwards may be limited in the second quarterevent of 2018.cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

On November 7, 2017,The Company must assess the Board awarded a total of 104,896 restricted shares, which were immediately vested,likelihood that its net deferred tax assets will be recovered from future taxable income, and to the independent directors in lieu of cash fees of $15,000 earned during the third quarter of 2017.

On November 7, 2017, the Board awarded a total of 143,707 restricted shares, which were immediately vested, to a consultant in lieu of cash fees of $20,500 earned in August, September and October of 2017.

Employment Agreement with Principal Shareholder

On October 10, 2017, the Board approved an employment agreement betweenextent the Company andbelieves that recovery is not likely, the Company establishes a principal shareholder,valuation allowance. Management’s judgment is required in determining the Company’s Vice President, Secretaryprovision for income taxes, deferred tax assets and Senior Technical Advisor.liabilities, and any valuation allowance recorded against the net deferred tax assets. The employment agreement supersededCompany recorded a full valuation allowance as of March 31, 2023 and replaced an employment agreement betweenDecember 31, 2022. Based on the available evidence, the Company and such principal shareholder dated July 25, 2014, which expired bybelieves it is more likely than not that it will not be able to utilize its terms on July 25, 2017. The initial term of the employment agreement commenced on October 1, 2017 and continues until December 31, 2019. However, the Company and such principal shareholder may terminate the employment agreement, at any time, with or without cause, by providing the other party with 30-days’ prior written notice. In the event such principal shareholder’s employment is terminated by the Company during the initial term without cause, such principal shareholder will be entitled to receive her base salary for an additional 30 days. Following the initial term, the Company and such principal shareholder may extend the employment agreement for additional one-year terms by mutual written agreement. Such principal shareholder will receive an annualized base salary of $150,000. During the initial term, such principal shareholder will be eligible to participatenet deferred tax assets in the Company’s sales incentive program for sales personnel, as in effectforeseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and as amended from time to time by the Company (the “Sales Program”). In connectionjudgments about its future taxable income that are based on assumptions that are consistent with the Sales Program, such principal shareholder will be entitled to a sales incentive equal to one-quarter of one percent (0.25%) ofCompany’s plans. Should the revenue collected and earnedactual amounts differ from the Company’s sales, payable quarterly in arrears. Subject toestimates, the approvalcarrying value of the independent membersCompany’s deferred tax assets could be materially impacted.

Note 11 – Related Party Transactions

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Board, such principal shareholderCompany, has a significant ownership interest in RSX.

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may be eligiblereceive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to participateeach annual expiration. During the three months ended March 31, 2023 and March 31, 2022, the Company paid $18,273 and $7,555, respectively, in commissions under this agreement.

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the 2017 Equity Plan. The independent membersamount of $10,900. We entered into positive change orders in March of $3,577 increasing the total of the Board have not approved such principal shareholder’s participationsecond sales order to $14,477. During the three months ended March 31, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the 2017 Equity Plan,three months ended March 31, 2023 in respect of these agreements.

Note 12 – Subsequent Events

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and such principal shareholder has not been granted, nor does such principal shareholder hold, any equity awards under thereunder.determined no material subsequent events occurred after March 31, 2023 for which disclosure was required.

25
 F-19

Designation of Principal Financial and Accounting Officer

On October 16, 2017, Dean S. Skupen notified the Board of his resignation as the Company’s Director of External Reporting and designated Principal Financial and Accounting Officer. The Company’s Chief Financial Officer will serve as the Company’s new designated Principal Financial and Accounting Officer.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our financial condition and results of operations should be read in conjunction with theour unaudited condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q,Quarterly Report, which include additional information about our accounting policies, practices, and the transactions underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016,2022, as filed with the SEC. In addition to our historical unaudited condensed consolidated financial information, the following discussion containsand other parts of this Quarterly Report contain forward-looking statementsinformation that reflect our plans, estimates,involves risks and beliefs.uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Cautionary Statements” appearing elsewhere herein and the risks and uncertainties described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed belowCompany’s filings with the SEC, and elsewhere in this Form 10-Q, particularly in Part II, Item 1A of this Quarterly Report entitled “Risk Factors.”

OverviewNon-GAAP Financial Measures

We develop, design, and distribute cultivation technologies for controlled environment agricultureTo supplement our financial results on U.S. generally accepted accounting principles (“CEA”GAAP”). Our customers include state-regulated cannabis cultivation facilities basis, we use non-GAAP measures including net bookings, backlog, as well as traditional indoor agricultural facilities,adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this Quarterly Report, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including organic herbcancellations and vegetable producers. change orders during the quarter.

Our technologies includebacklog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a comprehensive linenumber of application-specific lighting,reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.

Overview

CEA Industries, through our subsidiary, Surna Cultivation Technologies LLC, is a company focused on selling environmental control air sanitation, and cultivation facilities. Theseother technologies are designedand services to meet the specific environmental conditions required forControlled Environment Agriculture (“CEA”) industry. The CEA industry aims to optimize the use of horticultural resources such as water, energy, space, capital, and reducelabor, to create an agriculture business that is more efficient and more productive than those that use traditional farming methods. Typically, the CEA industry is focused on indoor agriculture and vertical farming.

Headquartered in Colorado, we leverage our experience in the CEA industry to bring our customers a variety of value-added technology solutions that help improve their overall crop quality and yield, optimize energy and water consumption. In addition, Surna offers mechanical design services specific to hydronic cooling, including mechanical equipmentefficiency, and piping design.

Our standard CEA project consists of small chillers, fan-coils,satisfy the evolving state and dehumidifiers, the major equipment items which we manufacture. Other required equipment items typically consist of large chillers, pumps, air separatorslocal codes, permitting and expansion tanks which we purchase from outside vendors.regulatory requirements. We believe our core competency is to provide integration services for these equipment items delivering a fully engineered, turn-key, single-source solution to our customers.

This integrated, single-sourced solution can create gross profit margin fluctuations depending on project design and the mix between our proprietary equipment, which typically generates a higher gross profit margin, and the equipment manufactureddo this by outside vendors. Further, quarterly fluctuations in gross profit margins can occur based on the timing of a project’s needs for our manufactured equipment versus third party manufactured equipment.

The demand for our integrated solution, including engineering design, proprietary equipment and third party manufactured equipment, is primarily based on the new construction of cannabis cultivation facilities in the U.S. and Canada. Due to continued uncertainty of the cannabis industry following the U.S. Justice Department’s announcement of its opposition to legalized cannabis in early 2017, we believe there may be some delay in new cannabis cultivation facilities by potential customers.

1

Recent and anticipated regulatory changes involving medicinal and/or recreational cannabis use in various jurisdictions, such as California, tend to be a leading indicator for the granting of licenses for new facility construction. As more new cultivation facilities become licensed, we in turn have an expanded set of opportunities and customers to whom will can potentially sell our systems.

For 2017, we are focused on: (i) new facility construction in California where recreational cannabis use was approved in November 2016, and (ii) in Canada where medicinal use is federally legal, and the federal government has signaled its intention to legalize recreational adult use in 2018.

Our marketing efforts are generally targeted to those persons who are actively seeking licenses to produce cannabis and, in many cases, our engineering services are needed for the completion of license applications. As such, the projects we quote may not advance to the contract stage due to either a failure of our prospect to receive licensure or to obtain project financing. In other cases, the successful licensee was either unknown to us at the time of application or elected to use a competing technology – rooftop duct system or traditional split air conditioning system – as opposed to our ductless hydronic system.

While our typical project sales contract is non-cancellable, there are risks that we may not realize the full contract value in a timely manner or at all. Completion of a sales contract is dependent upon our customers’ ability to secure, license and build their growing facility and take possession of the equipment. In order to address these risks, we have three key milestones built into our contracts.

● First, we provide our customer with engineering plans for which we require an upfront deposit before we begin our services. In many cases, the engineering phase is done as part of the license application or building permit process, represents on average approximately 10% of the total contract value, and takes approximately four to six weeks to complete. We previously required a larger initial deposit that covered engineering and initial equipment items; however, beginning in early 2017, we began offering our customers a variety of principal service and product offerings that include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting and climate control, and (viii) preventative maintenance services, through our partnership with a certified service contractor network, for CEA facilities.

26

Our revenue stream is currently derived primarily from supplying our products, services and technologies to licensed commercial indoor facilities operating in the cannabis industry. Our customers include state and provincial-regulated CEA growers located primarily in the U.S., Canada. We recently have developed customers in the non-cannabis CEA market to expand our market reach. Customers use our services for building new CEA facilities and expanding or retrofitting existing CEA facilities.

CEA growers currently face a challenging business environment that includes high energy costs, water usage and conservation issues, continuously evolving waste removal regulations, inflationary pressures, and labor shortages. In addition to these issues, our cannabis growing customers face increasingly rigorous quality standards and declining cannabis prices in a growing industry whose standards are constantly evolving.

We support our clients by providing integrated mechanical, electrical, and plumbing (“MEP”) engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. Over our 16 years in business, we have served hundreds of commercial indoor CEA facilities.

We believe our customers partner with us because we have the reputation and experience to help them make cost-conscious and effective decisions on the design and engineering of their indoor cultivation facilities. CEA facilities are resource intensive, and a growing list of states have implemented building code changes that limit energy consumption in cultivation facilities. Energy and resource efficiency is a high priority to us as engineers, and the senior engineers on our team hold the Leadership in Energy and Environmental Design (“LEED”) credential. We believe this sustainability-focused technical experience is crucial in the value we provide to our customers.

We have three core assets that we believe will support us as we pursue our business strategy. First, we enjoy strong relationships with relevant stakeholders in the CEA industry. Largely focused in the cannabis segment, our partnerships include relationships with new and existing growers, capital providers, consultants, independent contractors, and numerous other providers in the segment. These partnerships include agreements reached in 2022 with Merida Capital and Hydrobuilder Holdings LLC. In June we announced a marketing arrangement with Merida Capital, a cannabis-focused private equity firm, whereby Merida will use CEA Industries Inc. as its sole provider of certain products and services for its indoor cultivation facilities. This relationship resulted in a new contract in October 2022 with one of Merida’s Connecticut based clients. In November of 2022 we announced a strategic alliance with Hydrobuilder Holdings that we believe will result in more project opportunities.

Second, our experience in this industry over time has built up specialized engineering know-how and experience. We have been serving indoor cultivators since 2006 and designing CEA cultivation facilities since 2016. Since then, we have tested and solidified best practices from designing environmental control systems for CEA cultivation facilities.

Third, we have a line of proprietary environmental control products that support the specific growing environments that our customers want. We believe these products offer significant benefits to our customers.

Shares of our common stock and warrants are traded on the Nasdaq Capital Markets under the ticker symbols “CEAD” and “CEADW”, respectively.

Impact of the COVID-19 Pandemic on Our Business

As a result of the government measures to control the COVID-19 pandemic, there continue to be disruptions in business operations around the world, with a persistent impact on our business.

We still are experiencing delays with our international supply of products and shipments from vendors. While these delays have improved in recent months, we, along with many other importers of goods across all industries, continue to experience supply chain disruption. Also, shipping times are still longer than they were prior to the COVID-19 pandemic. We continue to work diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they are out of our control.

27

Impact of Ukrainian Conflict

We believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending for the Ukraine and funding of our country’s response. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

Our Bookings, Backlog and Revenue

During the three months ended March 31, 2023, we executed new sales contracts with a total contract value of $767,000. During this same period, we had positive change orders of $59,000. After adjustments for these change orders, our net bookings in the three months ended March 31, 2023 were $826,000, representing an increase of $619,000 (or 300%) from net bookings of $206,000 in the fourth quarter of 2022.

Our backlog at March 31, 2023 was $1,869,000, a decrease of $3,709,000, or 67%, from December 31, 2022. The decrease in backlog is the result of higher revenue in the first quarter and lower initial deposit for engineering only.bookings in the second half of 2022. Our strategybacklog at March 31, 2023 includes booked sales orders of $379,000 (20% of the total backlog) from three customers that we do not expect to be realized until 2024, if at all. Included in the 2024 projected revenue is to secureone booked sales order of $279,000 (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. We believe the sales contract and commence the engineering portion of the project earlier, which is important for a number of reasons: (i) we can assist our customers with their engineering and design plans as part of their licensing application process, (ii) we are better positioned to utilize our technology for the project at an earlier stage, and (iii) we are able to help reduce the customer’s time to market.

● Second, upon completion of the engineering phase, it may take our customer on average five months to complete the facility build-out, with possible delays due to financing or other aspects which are beyond our control. Customer delaysorders in obtaining financing and completing facility build-out make the timing of completion of our sales contract unpredictable. For our protection, before we begin manufacturing our proprietary equipment items, we require an upfront deposit that brings the total to approximately 50% of the contract value.

● And third, the last phase of our contract involves procurement and drop-ship delivery of third party manufactured equipment items and commissioning of the system after installation, performed by third parties, is completed. We undertake this step only upon payment of the third and final deposit of the remaining 50% of the contract value.

Given the timing of the deliverables of our sales contracts, we can experience large variances in quarterly revenue. Our revenue recognition is dependent upon shipment of the equipmentthese portions of our sales contracts, which, in many cases,backlog have an elevated level of risk and may, ultimately, be delayed whileor cancelled by our customers complete permitting or preparation of their facilities for equipment installation.customers. Therefore, investors should not view backlog as earned revenue.

As of September 30, 2017, the unearnedThe following table sets forth: (i) our beginning backlog (the remaining contract value of our outstanding sales contracts for which we have received an initial deposit increased to $4,311,000 (“Q3 2017 backlog”). Our Q3 2017 backlog consists of: (i) $1,972,000as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the three months ended September 30, 2017, and (ii) the remaining $2,339,000 is attributable to prior quarters. About 45% of our Q3 2017 backlog (up from 30% in Q2 2017) is attributable to projectsperiod for which we received an initial deposit, net of any adjustments including cancellations and change orders during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings, less recognized revenue). Based on the current economic climate and our cost cutting measures, there is no assurance that we will be able to continue to obtain the level of bookings that we have not received a further deposithad in the past and or fulfill our current backlog, and we may experience contract cancellations, project scope reductions and project delays.

Our recognized revenue for the quarter ended March 31, 2023, in the table below, excludes $148,776 in revenue arising from the forfeiture of non-refundable deposits from former customers on our proprietary equipment and, as a result, there are potential riskspreviously cancelled contracts. The contracts were removed from the backlog at the time of project cancellation or delay.cancellation.

  For the quarter ended 
  

March 31,

2022

  

June 30,

2022

  

September 30,

2022

  

December 31,

2022

  

March 31,

2023

 
Backlog, beginning balance $10,818,000  $11,179,000  $9,698,000  $6,832,000  $5,577,000 
Net bookings, current period $2,105,000  $1,534,000  $2,197,000  $206,000  $826,000 
Recognized revenue, current period $1,744,000  $3,015,000  $5,063,000  $1,461,000  $4,534,000 
Backlog, ending balance $11,179,000  $9,698,000  $6,832,000  $5,577,000  $1,869,000 

28
 2

The increase in our Q3 2017 backlogcompletion of a customer’s new build facility project is attributabledependent upon the customer’s ability to new contracts awarded insecure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the third quarter totaling $2,385,000, bringing our total new sales contracts awarded for the nine months ended September 30, 2017 to $7,182,000. However, based on the current status of our outstanding sales contracts, we believe at least 50% of our Q3 2017 backlog could be recognized as revenue in Q4 2017.

During Q3 2017, we began implementing a two-tiered sales model. The first tier involves direct sales efforts in various regions across the U.S. and Canada. We currently have three employees assigned to direct sales and one employee assigned to inside sales. The second tier involves utilization of our two technical advisors and their expertise to complement the direct sales efforts. In furtherance of this new model, our previous Chief Executive Officer shifted his focus to developing the California market (including his physical relocation in the state) and he now serves as our Vice President of Business Development – West Coast. We expect his industry experience combined with his knowledge of our business to help us capture market share in the largest growth area in the U.S. We have also hired, or intend to hire, additional direct sales personnel for the East Coast, Pacific Northwest and other North American markets.

We are continuing our efforts to increase our bookings of new sales contracts and grow our revenue. Specifically, we are: (i) in the process of upgrading our lead generation and business development system, (ii) overhauling our project management processes, (iii) continuing to build our direct sales team with more experienced personnel, (iv) reallocating sales territories to allow the sales personnel to focus on individual regional needs and to become more personally involved in their markets, and (v) implementing improved management information systems to increase sales pipeline visibility and the associated accountability for each direct salesperson. We also recently developed a sales quotation tool reducingequipment. Accordingly, the time it takes for these customers to prepare detailed system proposals. We anticipate this tool will also shortencomplete a new build project, which corresponds to when we are able to recognize revenue, is driven by numerous factors including: (i) the learning curvelarge number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation systems; (vii) the availability of power; and (viii) delays that are typical in completing any construction project.

As has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition of our new sales personnel. backlog as of March 31, 2023.

We are realizinghave provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining performance obligations (i.e., our Q1 2023 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment paid contracts. There continues to be significant uncertainty regarding the benefits of a preferred pricing program recently received from onetiming of our majorrecognition of revenue on our Q1 2023 backlog. Refer to the Revenue Recognition section of Note 1 in our condensed consolidated financial statements, included as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.

Our backlog, remaining performance obligations, and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue, and remaining performance obligations. Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations, backlog and net bookings.

Results of Operations

Comparison of Three Months Ended March 31, 2023 and March 31, 2022

Revenues and Cost of Goods Sold

Revenue for the three months ended March 31, 2023 was $4,683,000, compared to $1,744,000 for the three months ended March 31, 2022, representing an increase of $2,939,000, or 169%. The increase was primarily due to improvements in our supply chain and the ability to deliver products with fewer delays on contract fulfillment and revenue recognition on existing contracts.

Cost of revenue increased by $2,175,000, or 132%, from $1,654,000 for the three months ended March 31, 2022 to $3,829,000 for the three months ended March 31, 2023. The increase was primarily due to an increase in revenue and a decrease in fixed costs as a percentage of revenue, as discussed below.

Our gross profit for the three months ended March 31, 2023 was $853,000 compared to $91,000 for the three months ended March 31, 2022, an increase of 837%. Gross profit margin increased by 13 percentage points from 5.2% for the three months ended March 31, 2022 to 18.2% for the three months ended March 31, 2023 primarily due to higher revenue and a decrease in fixed costs as a percentage of revenue, as described below. Additionally, total revenue in the three months ended March 31, 2023 includes $149,000 from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $391,000, or 8.3% of total revenue, for the three months ended March 31, 2023 as compared to $359,000, or 21% of total revenue, for the three months ended March 31, 2022. The increase of $32,000 was primarily due to an increase in salaries and benefits (including stock-based compensation) of $30,000.

29

Our variable costs (which include the cost of equipment, suppliers, who awarded us national account status. As new jurisdictionsoutside engineering costs, shipping and handling, travel and warranty costs) totaled $3,439,000, or 73% of total revenue, during the three months ended March 31, 2023, as compared to $1,295,000, or 74% of total revenue, in the three months ended March 31, 2022. The increase in variable costs was primarily due to: (i) an increase in equipment costs of $2,136,000 driven by higher revenue and slightly lower equipment margins, (ii) an increase in excess and obsolete inventory expense of $30,000, (iii) an increase in warranty expense of $6,000, offset by, (iv) a decrease in outside engineering costs of $17,000, and (v) a decrease in travel of $13,000.

We continue to ease regulationfocus on gross margin improvement through a combination of cannabis and larger scale projects becomeefforts, including more prevalent as the market matures and investment capital becomes more readily available, we believe we are well positioned to address the new challenges and opportunities the market presents.

Nonetheless, the ever-changing naturedisciplined pricing, better absorption of our salesfixed costs as we convert our bookings into revenue, and the needsimplementation over time of lower-cost supplier alternatives.

Operating Expenses

Operating expenses decreased to $1,299,000 for the three months ended March 31, 2023, from $1,702,000 for the three months ended March 31, 2022, a decrease of $403,000, or 24%. The operating expense decrease consisted of: (i) a decrease in selling, general and administrative expenses (“SG&A expenses”) of $291,000, (ii) a decrease in product development of $63,000, and (iii) a decrease in advertising and marketing expenses of $49,000.

Our decrease in SG&A expenses for the three months ended March 31, 2023 compared to the three months ended March 31, 2022, was primarily due to: (i) a decrease of $202,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) a decrease in accounting and other professional fees of $127,000, (iii) a decrease in travel of $21,000, (iv) a decrease of $12,000 for facility and office expenses, (v) a decrease in loss on asset disposal of $5,000, offset by (i) an increase in insurance of $21,000, (ii) an increase for investor relations and board fees of $21,000, (iii) an increase in bad debt expense of $20,000, (iv) an increase of $11,000 for commissions, and (v) an increase in business taxes and licenses of $3,000.

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $47,000, (ii) a decrease in R&D consulting and materials expense of $10,000, and a decrease in travel of $6,000.

The decrease in marketing expenses was primarily due to (i) a decrease in outside services and other marketing expenses of $31,000, (ii) a decrease in advertising and promotion of $28,000, offset by (iii) an increase of $11,000 in salaries and benefits, primarily due to severance payments from our reduction in force in February.

Operating Income (Loss)

We recognized an operating loss of $446,000 for the three months ended March 31, 2023, as compared to an operating loss of $1,611,000 for the three months ended March 31, 2022, a decrease of $1,165,000 or 72%. The operating loss for the three months ended March 31, 2023 included $147,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense, compared to $93,000 of non-cash, stock-based compensation and $7,000 of depreciation expense for the three months ended March 31, 2022. Excluding these non-cash items, our operating loss decreased by $1,219,000.

Other Income (Expense)

We recognized other income (net) of $15,000 for the three months ended March 31, 2023, compared to other income (net) of $188,000 for the three months ended March 31, 2022. Other income for the three months ended March 31, 2023 primarily consisted of interest income on a money market account. Other income for the three months ended March 31, 2022 primarily consisted of proceeds from an insurance settlement.

30

Net Income (Loss)

Overall, we recognized a net loss of $431,000 for the three months ended March 31, 2023, as compared to a net loss of $1,423,000 for the three months ended March 31, 2022, a decrease of $992,000 or 70%. The net loss for the three months ended March 31, 2023 included $147,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense, compared to $93,000 of non-cash, stock-based compensation and $7,000 of depreciation expense for the three months ended March 31, 2022. Excluding these non-cash items, our net loss decreased by $1,045,000.

Financial Condition, Liquidity and Capital Resources

Cash, Cash Equivalents

As of March 31, 2023, we had cash and cash equivalents of $15,948,000, compared to cash and cash equivalents of $18,637,000 as of December 31, 2022. The $2,689,000 decrease in cash and cash equivalents during the three months ended March 31, 2023, was primarily the result of cash used in operations. Our cash is held in bank depository accounts in a financial institution. During the three months ended March 31, 2023, we held deposits in this financial institution that exceeded the federally insured amount.

As of March 31, 2023, we had accounts receivable (net of allowance for doubtful accounts) of $62,000, inventory (net of excess and obsolete allowance) of $441,000, and prepaid expenses and other assets of $471,000 (including $219,000 in advance payments on inventory purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers make it difficultare funded on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we continue to pursue larger projects.

As of March 31, 2023, we had total accounts payable and accrued expenses of $1,164,000, deferred revenue of $1,103,000, and the current portion of operating lease liability of $120,000. As of March 31, 2023, we had working capital of $14,535,000, compared to working capital of $14,724,000 as of December 31, 2022. The decrease in our working capital was primarily related to (i) a decrease in deferred revenue of $3,236,000, (ii) a decrease in cash of $2,689,000, and (iii) a decrease in prepaid expense of $1,019,000.

We currently intend to retain all available funds and any future earnings for us touse in the operation and expansion of our business. We have never declared or paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future.

Because of the post-pandemic macro-economic and CEA industry economy that has developed during 2021 and 2022, and is continuing into 2023, we cannot predict whenthe continuing level of working capital that we will recognize revenue. We continuehave in the future. Additionally, we cannot predict that our future financial position will not deteriorate due to remain focused on increasingcancelled or delayed contract fulfillment, reduced sales and our sales contract backlog and quoting larger projects in an effortability to increase revenue.

Since the second quarter of 2017,perform our contracts. As mentioned elsewhere, we have allocated moretaken steps to conserve our cash resources to improvingby reducing staff and taking other cost-cutting measures.

Summary of Cash Flows

The following summarizes our internal project management process in an effort to shortenapproximate cash flows for the time period from the execution of a sales contract to commissioning of the customer’s system. Commissioning is the last step of the installation process of our system, where we require our customers to pay to have our representativesthree months ended March 31, 2023 and representatives from our suppliers on site to initially start the system, balance the equipment, achieve the designed temperature and identify any installation issues. We have worked to improve our internal and external kick-off meetings for smoother transition from sales contact execution to project management and from project management to commissioning. Processes and documentation have been established and integrated with our CRM system to allow us to more efficiently identify and manage project execution.March 31, 2022:

  

For the Three Months Ended

March 31,

 
  2023  2022 
Net cash used in operating activities $(2,689,000) $193,000 
Net cash used in investing activities  -   (14,000)
Net cash provided by financing activities  -   19,695,000 
Net increase (decrease) in cash $(2,689,000) $19,874,000 

For example, we created customer project launch documentation to ensure all necessary information is timely conveyed and received, project scheduling and timing is adhered to, invoice and billing systems are accurate, equipment delivery and installation are completed on time, and project commissioning meets our desires and those of our customer. We have also initiated a weekly project tracking update document depicting a visual representation of the current progress and milestones of each customer’s project, which is delivered to our sales and project management teams as well as the customer’s project and management teams. This tracking communicates current status, pending activities and next steps, supplier involvement and key issues needing attention. While we believe our efforts in improving project management can lead to earlier completion our customers’ projects, external factors outside of our control, such as the customers’ ability to secure, license, finance and build their growing facility, can significantly impact the delivery and customer installation of our equipment.

31
 

Operating Activities

We incurred a net loss for the three months ended March 31, 2023 of $431,000 and have an accumulated deficit of $34,710,000 as of March 31, 2023.

Cash used in operations for the three months ended March 31, 2023 was $2,689,000 compared to cash provided from operating activities of $193,000 for the three months ended March 31, 2022, an increase in cash usage of $2,882,000.

The increase in cash used in operating activities during the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, was primarily attributable to: (i) an increase in cash used to fund working capital of $4,063,000, (ii) a decrease in net loss of $992,000, and (iii) an increase in non-cash operating charges of $189,000.

The decrease in our working capital was primarily related to (i) a decrease in deferred revenue of $3,236,000, (ii) a decrease in cash of $2,689,000, and (iii) a decrease in prepaid expense of $1,019,000.

The increase in non-cash operating charges was primarily due to higher share-based compensation of $145,000 and an increase in the provision for excess and obsolete inventory of $30,000.

Investing Activities

Cash used in investing activities during the three months ended March 31, 2023 was $0. Cash used in investing activities during the three months ended March 31, 2022 of $14,000 was related to the purchase of property and equipment.

Financing Activities

There were no cash flows from financing activities during the three months ended March 31, 2023.

Cash flows from financing activities during the three months ended March 31, 2022, was the result of cash proceeds from the sale of common stock and warrants (net of issuance costs) of $21,711,000, offset by a cash payment of $2,016,000 for the redemption of series B preferred stock, including related dividends.

Common Stock Equity Offering

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $21,711,000 for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.16, during the period commencing August 9, 2022, and expiring on February 10, 2027.

The net proceeds from the offering will be used to advance the Company’s organic growth and new product initiatives, to pursue select acquisitions, and for general corporate and working capital purposes. In connection with this offering, we received approval to list our common stock on the Nasdaq Capital Market under the symbol “CEAD” and our warrants under the symbol “CEADW”. Effective February 10, 2022, trading of both shares of the Company’s common stock and certain of the Company’s warrants commenced on the Nasdaq.

332
 

Recent DevelopmentsInflation

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

Contractual Payment Obligations

As of March 31, 2023, our contractual payment obligations consisted of a building lease. Refer to Note 3 -2Promissory Notes, Leases of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of building lease.

Commitments and Contingencies

Refer to Note 6 -Shareholders’ Equity,– Commitments and Contingencies of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of commitments and contingencies.

Off-Balance Sheet Arrangements

We are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2023, we had no off-balance sheet arrangements. During the three months ended March 31, 2023, we did not engage in any off-balance sheet financing activities other than those included in the “Contractual Payment Obligations” discussed above and those reflected in Note 76 of our condensed consolidated financial statements.

Recent Developments

Refer to Note 12 -Subsequent Events of the Notesnotes to Unaudited Condensed Consolidated Financial Statements,condensed consolidated financial statements, included in Part I, Item 1as part of this Quarterly Report for the morecertain significant events occurring since September 30, 2017.March 31, 2023.

Critical Accounting Policies and Significant Judgments and Estimates

This discussion and analysis of our financial condition and results of operations is based upon our interim unaudited condensed consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States.States of America. Certain accounting policies are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate. For information regarding our critical accounting policies as well as recent accounting pronouncements, see Note 1Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to the consolidated financial statements.

Resultsperformance obligations under contracts with customers, standalone selling prices, timing of Operations

The following discussion should be read in conjunctionexpected revenue recognition on remaining performance obligations under contracts with our condensed consolidated financial statements and the related notes included in this Form 10-Q.

Comparisoncustomers, valuation of the Three Months Ended September 30, 2017 and 2016

Revenues and Costintangible assets, valuation of Goods Sold

Revenue for the three months ended September 30, 2017 was $1,566,000 compared to $1,171,000 for the three months ended September 30, 2016, an increase of $395,000, or 34%.

Cost of revenue increased by 56% from $754,000 for the three months ended September 30, 2016 to $1,175,000 for the three months ended September 30, 2017.

The gross profit for the three months ended September 30, 2017 was $391,000 compared to $417,000 for the three months ended September 30, 2016. Gross profit margin decreased by 11 percentage points from 36% for the three months ended September 30, 2016 to 25% for the three months ended September 30, 2017. This decrease was caused by an unfavorable sales mix of lower margin products (i.e., equipment manufactured by outside vendors) and increased manufacturing overhead compared to the three months ended September 30, 2016.

Our cost of revenue cost structure is comprised of both a fixed and variable component. The fixed cost component represents engineering, manufacturing and project management salaries and benefits and manufacturing overhead that totaled $331,000, or 21% of total revenue, for the three months ended September 30, 2017 as compared to $258,000, or 22% of total revenue, for the three months ended September 30, 2016. The increase of $72,000 was due to an increase in salaries and benefits of approximately $33,000 and stock compensation of approximately $38,000. The variable cost component which represents our cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs of $844,000, or 54% of total revenue, in the three months ended September 30, 2017 as compared to $495,000, or 42% of total revenue, in the three months ended September 30, 2016. Variable costs for the three months ended September 30, 2017 were higher than the three months ended September 30, 2016 primarily because of higher equipment costs. Equipment costs of revenue increased 111% for the three months ended September 30, 2017 compared to an increase in revenue of 62% for the same period reflecting a change in product mix. Additionally, variable costs were favorably impacted by reductions in outside engineering and warranty costs totaling $70,000.

4

Operating expenses increased by 148% from $654,000 for the three months ended September 30, 2016 to $1,625,000 for the three months ended September 30, 2017, an increase of $971,000. The operating expense increase consisted of: (i) an increase in selling, general and administrative expenses (“SG&A expenses”) of $862,000, and (ii) an increase in advertising and marketing of $123,000, offset by (iii) a decrease in product development expense of $15,000.

The increase in SG&A expenses for the three months ended September 30, 2017 compared to the three months ended September 30, 2016 is due primarily to: (i) an increase of $452,000 in equity-related employee compensation, (ii) an increase of $220,000 in salaries and benefits, (iii) an increase of $115,000 in legal and consulting fees, and (iv) an increase of $113,000 in cash and equity-based director fees.

The increase in marketing expenses have been primarily the result of: (i) our investment in re-branding the Surna name, including approximately $55,000 for the redevelopment of our website and marketing materials, (ii) our increased presence at industry trade shows and events resulting in increased expenses of $25,000, and (iii) marketing salaries and benefits (including equity related-compensation) which increased by approximately $24,000.

Other expenses decreased by 43% from $431,000 for the three months ended September 30, 2016 to $245,000 for the three months ended September 30, 2017. This decrease is primarily related to the decrease in the amortization of debt discount and interest expense on convertible promissory notes. The convertible promissory notes converted in the fourth quarter of 2016 and the first quarter of 2017. Therefore, in the three months ended September 30, 2017, we did not have the associated amortization of these debt discounts. However, we did incur a loss on extinguishment of debt of $228,000 in the three months ended September 30, 2017, due to the conversion of certain notes.

We realized an operating loss of $1,234,000 for the three months ended September 30, 2017 as compared to an operating loss of $237,000 for the three months ended September 30, 2016. However, we incurred $626,000 of non-cash, equity-based compensation, expenses in the three months ended September 30, 2017 as compared to $0 for the three months ended September 30, 2016. Excluding these non-cash items, our operating loss increased by $371,000.

Overall, we realized a net lossvaluation of $1,478,000 for the three months ended September 30, 2017 as compared to a net loss of $669,000 for the three months ended September 30, 2016, an increase of $809,000. However, we incurred $626,000 of non-cash, equity-based compensation expenses and $245,000 of non-cash, debt-related costs in the three months ended September 30, 2017 as compared to non-cash, debt-related costs of $353,000 in the three months ended September 30, 2016. Excluding these non-cash items, our net loss increased by $291,000.

Comparison of the Nine Months Ended September 30, 2017 and 2016

Revenues and Cost of Goods Sold

Revenue for the nine months ended September 30, 2017 was $4,901,000 compared to $5,561,000 for the nine months ended September 30, 2016, a decline of $660,000, or 12%. The decline in revenue is mainly attributable to the volume of new sales contracts and the timing of equipment delivery under our executed sales contracts. While new contracts increase our backlog, revenue recognition for the equipment portions of our sales contracts is delayed in many cases as our customers complete permitting or preparation of their facilities for equipment installation. The decline in revenue was also due to continuing uncertainty of the cannabis industry following the new Trump Administration’s announcement of its opposition to legalized cannabis, which we believe may be delaying new cannabis cultivation facility projects by potential customers.

Cost of revenue decreased by 2% from $3,742,000 for the nine months ended September 30, 2016 to $3,669,000 for the nine months ended September 30, 2017. The gross margin decreased by eight percentage points from 33% for the nine months ended September 30, 2016 to 25% for the nine months ended September 30, 2017. Our cost of revenue cost structure is comprised of both a fixed and variable component. The fixed cost component represents engineering, manufacturing and project management salaries and benefits totaled $897,000, or 18% of total revenue, for the nine months ended September 30, 2017 as compared to $830,000, or 15% of total revenue, for the nine months ended September 30, 2016. The increase of $67,000 was due to an increase in our engineering and project management salaries and benefits (including equity-related compensation) and other overhead of $150,000. The increase was offset by a decrease in manufacturing salaries and benefits of $83,000 (including equity-related compensation). The increase in fixed costs as a percentage of revenue also resulted from a 12% decline in revenue in the nine months ended September 30, 2017 compared to the nine months ended September 30, 2016. The variable cost component represents our cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs, which was $2,771,000, or 57% of total revenue, in the nine months ended September 30, 2017 as compared to $2,912,000, or 52% of total revenue, in the nine months ended September 30, 2016. The 2016 costs were higher due to a warranty charge of approximately $500,000 to replace a customer’s system. Equipment cost of revenue for 2017 increased by $186,000 and we increased our allowance for slow moving and obsolete inventory by $208,000 for specifically-built inventory sold to a customer, who would not accept delivery. We continue to attempt to reduce our variable costs through more competitive prices from our vendors and reduced warranty expenditures.

5

Operating expenses increased by 114% from $1,990,000 for the nine months ended September 30, 2016 to $4,253,000 for the nine months ended September 30, 2017.

The most significant component of our increased operating expenses in the nine months ended September 30, 2017 was SG&A expenses. SG&A expenses increased by $1,959,000, or 126%, from $1,559,000 for the nine months ended September 30, 2016 to $3,518,000 for the nine months ended September 30, 2017. The increase in SG&A expenses for the nine months ended September 30, 2017 compared to the prior period is due primarily to the following: (i) an increase of $717,000 for additional compensation to our independent directors (comprised of $459,000 for equity-related compensation for new directors, including $68,000 for cancelled options, $51,000 in cash retainer fees, and $207,000 for equity-related compensation to a previous director), (ii) an increase of $453,000 in equity-related compensation to employees, (iii) an increase of $368,000 in salaries and wages primarily related additional sales staff, (iv) an increase of $321,000 professional and consulting fees that included a one-time charge of $81,000 for a cash and equity-related compensation to an investment banking firm, and (v) an increase of $67,000 in travel expenses.

Marketing expenses increased by $329,000 from $155,000 in the nine months ended September 30, 2016 to $484,000 for the nine months ended September 30, 2017, an increase of 212%. We have invested in re-branding the Surna name, including approximately $153,000 for the redevelopment of our website and marketing materials. We have also increased our presence at industry trade shows, events and in publications resulting in increased expenses of approximately $105,000. Marketing salaries and benefits (including equity-based compensation) have increased $49,000.

Other expenses decreased by 73% from $1,947,000 for the nine months ended September 30, 2016 to $532,000 for the nine months ended September 30, 2017. This decrease was primarily related to a reduction in the amortization of debt discount on convertible promissory notes. The convertible promissory notes converted in the fourth quarter of 2016 and the first quarter of 2017. Therefore, the second and third quarter of 2017 did not have the associated amortization of these debt discounts. We did incur a loss on extinguishment of debt of $643,000 in the nine months ended September 30, 2017, due to conversion of certain notes. As of September 30, 2017, we had no long-term debt.

Overall, we realized a net loss of $3,553,000 for the nine months ended September 30, 2017 compared to a net loss of $2,118,000 for the nine months ended September 30, 2016, an increase of $1,434,000, or 68%.

Liquidity and Capital Resources

The following summarizes our cash flows:

  For the Nine Months Ended 
  June 30, 
  2017  2016 
Cash (used in) provided by operating activities $(1,961,000) $35,000 
Cash flows provided by investing activities  75,000   15,000 
Cash flows provided by (used in) financing activities  2,867,000   (145,000)
Net change in cash $981,000  $(95,000)

6

We have never reported net income. We incurred net losses for the nine months ended September 30, 2017 and 2016 and have an accumulated deficit of $17,889,000 as of September 30, 2017. We had a deficit in working capital (current liabilities in excess of current assets) of $667,000 as of September 30, 2017 as compared to a working capital deficit of $2,860,000 as of December 31, 2016. This improvement in working capital during the nine months ended September 30, 2017 is primarily related to: (i) the $2,685,000 raised in a private placement of our common stock and attached warrants, (ii) the conversion to common stock of the convertible promissory notes and related interest payable, and (iii) the conversion of certain other notes. We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. Since our inception, we have raised capital through private sales of common stock and debt securities. Our future success is dependent upon our ability to achieve profitable operations and generate cash from operating activities. There is no guarantee that we will be able to generate enough revenue and/or raise sufficient capital to support our operations. As of September 30, 2017 and December 31, 2016, we had a cash balance of $1,301,000 and $320,000, respectively.

Our consolidated financial statements have been presented on a going concern basis, which contemplates the realization ofdeferred tax assets and the satisfaction of liabilities, in the normal course of business. Our independent registered public accounting firm included in its audit opinion on our financial statements for the year ended December 31, 2016 a statement that there is substantial doubt as to our ability to continue as a going concern.warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

We will likely need to raise debt and/or equity financing during the first half of 2018 in order to continue our operations and achieve our growth targets. There can be no assurance however that we will be able to raise such financing in sufficient amounts or on acceptable terms, or at all.

If, as we move into the first half of 2018, we determine that our revenue and operating results are not satisfactory, we intend to explore various operating cost reductions. Even if we were able to reduce operating costs, we would still likely need to seek additional debt and/or equity financing. The precise amount and timing of the funding needs will depend on a number of factors, including the market demand for our products and services, the timing of our receipt of deposits from our customers under our sales contracts, our management of working capital, and the continuation of normal payment terms and conditions for purchase of goods and services.

Cash Requirements

As of September 30, 2017, our cash balance was $1,301,000, a decrease of 3.9% from our cash balance of $1,353,000 as of June 30, 2017. Nonetheless management has determined the current cash flow from operations may not be sufficient to fund our operations over the next twelve months. Based on management’s estimate for our operational cash requirements, we will likely require additional capital during the first half of 2018.

If we are unable to generate sufficient cash flow from operations, make adjustments to our payment arrangements or raise sufficient additional capital through future debt and equity financings or strategic and collaborative ventures with potential partners, we will likely have to reduce the size and scope of our operations. Our officers and shareholders have not made any written or oral agreement to provide us additional financing. There can be no assurance that we will be able to continue to raise capital on terms and conditions that are deemed acceptable to us, or at all.

Operating Activities

Cash used in operations for the nine months ended September 30, 2017 was $1,961,000 compared to cash provided by operations of $35,000 for the nine months ended September 30, 2016, a change of $1,996,000. The additional cash usage is primarily attributable to an increase in net loss of $1,434,000, which was offset by an increase in non-cash charges of $234,000, and additional cash used for working capital of $796,000. During the nine months ended September 30, 2017, significant non-cash items included: (i) equity-related compensation of $1,271,000, (ii) loss on extinguishment of debt of $643,000 and (iii) gain on the change in derivative liability of $212,000.

7

Investing Activities

Cash provided by investing activities for the nine months ended September 30, 2017 was approximately $75,000 compared to cash provided by investing activities of $15,000 for the nine months ended September 30, 2016. During the nine months ended September 30, 2017, we received payments of approximately $157,000 on notes receivable offset by payments for deposits and investments in equipment and other assets of $82,000. During the nine months ended September 30, 2016 we received net payments of approximately $20,000 on notes receivable, had net proceeds of $33,000 from the sale of property and equipment, and invested in equipment and other assets totaling $38,000.

Financing Activities

Cash provided by financing activities for the nine months ended September 30, 2017 was $2,867,000 compared to cash used in financing activities of $145,000 for the nine months ended September 30, 2016. During the nine months ended September 30, 2017, we completed a private placement for the sale of shares of our common stock, with attached warrants, resulting in net proceeds of $2,685,000. During the nine months ended September 30, 2017, also in the first quarter 2017 we issued two unsecured promissory notes for aggregate proceeds of $500,000 and made payments of $270,000 to extinguish the principal under our remaining convertible promissory notes.

Inflation

In the opinion of management, inflation has not and will not have a material effect on our operations in the immediate future. Management will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.

Contractual Payment Obligations

As of September 30, 2017, our contractual payment obligations consisted of a building lease. On June 27, 2017, we executed a lease, to be effective September 29, 2017, for our manufacturing and office space. The term of the lease commenced September 29, 2017 and continues through August 31, 2022. We will occupy our current space at a rate of $12,967 per month until January 1, 2018. On January 2, 2018, the space will be expanded and the monthly rental rate will increase to $18,979 until August 31, 2018. Beginning September 1, 2018, the monthly rent will increase by 3% each year through the end of the lease.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSUREDISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, andtherefore are not required to provide the information under this item.

33

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer (“CEO”)Chief Executive Officer and principal financialour Principal Financial and accounting officer (“PFAO”),Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act,Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our CEOChief Executive Officer and PFAOPrincipal Financial and Accounting Officer concluded that becauseas a result of certain material weaknessesweakness in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 20162022 filed with the SEC, our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act were not effective as of as of September 30, 2017.March 31, 2023.

8

We did not maintain effective controls over certain aspects of the financial reporting process becausebecause: (i) we lackedlack a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements. In addition,requirements, (ii) there wasis inadequate segregation of duties due to the limitation on theour limited number of accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on, for our accounting personnel.financial reporting.

We intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and nature, segregation of all conflicting dutiesour financial resources, remediating the several identified weaknesses has not always been possible and may not be economically feasible.feasible now or in the future.

Changes in Internal Control over Financial Reporting

For the nine months ended September 30, 2017, there has beenThere were no changechanges identified in connection with our internal control over financial reporting during the three months ended March 31, 2023, that hashave materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

We are not presentlycurrently a party to any material legal proceedings, nor are we aware of any pending or threatened litigation that would have a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation be resolved unfavorably. We have and will continue to have commercial disputes arising in the ordinary course of our business.

Item 1A. Risk Factors

In addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under the caption “Item 1A—Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 20162022 that could materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not presently known to us or that we currently consider to be immaterial to our operations. There have been no material changes in the significant factors that may affect our business and operations as described in “Item 1A—Risk Factors” of the Annual Report on 10-K for the year ended December 31, 2016.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended September 30, 2017, we issued 5,600,000 unregistered shares of common stock, at a price per share of approximately $0.096 per share, in settlement of two promissory notes, each in the original principal amount of $268,750.None.

34

Item 3. Defaults Uponupon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.Not applicable.

Item 5. Other Information

Regulation FD Disclosure.

Press Release Announcing Financial Results

On November 14, 2017, we issuedApril 10, 2023, the Company received a press release announcing our financial condition and resultsletter from the Listing Qualifications Department of operationsthe Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the three and nine months ended September 30 2017.consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The press release is attached hereto as Exhibit 99.1.Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until October 9, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

The foregoing information, includingIn order to regain compliance with Nasdaq’s minimum bid price requirement, the exhibits related thereto, is furnished in response to Item 2.02Company’s common stock must maintain a minimum closing bid price of Form 8-K and shall$1.00 for at least ten consecutive business days during the Compliance Period. In the event the Company does not be deemed “filed” for purposes of Section 18regain compliance by the end of the Exchange Act, nor shallCompliance Period, the Company may be eligible for additional time to regain compliance. To qualify for the additional time, the Company will be required to meet the continued listing requirement for the market value of its publicly held shares and all the other listing standards for The Nasdaq Capital Market and will need to provide written plan to cure the deficiency during the second compliance period. The Company may be granted an additional 180 calendar days to regain compliance if the plan is accepted by Nasdaq. However, if it appears to Nasdaq that the Company will be deemed incorporated by reference in any disclosure documentunable to cure the deficiency, or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide notice that the Company’s common stock will be subject to delisting.

The letter has no immediate impact on the listing of the Company, except as shallCompany’s common stock, which will continue to be expressly set forth by specific reference in such document.listed and traded on The Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of The Nasdaq Capital Market.

Item 6. Exhibits

The documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

35
 9

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date : November 14, 2017SURNACEA INDUSTRIES INC.
(the “Registrant”)
By:
Dated: May 15, 2023By:/s/ Chris BechtelAnthony K. McDonald
Chris Bechtel, Anthony K. McDonald
Chief Executive Officer and President
(Principal Executive Officer)
Dated: May 15, 2023By:/s/ Paul KellyIan K. Patel
Paul Kelly, Ian K. Patel
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)

36
 10

EXHIBIT INDEX

Exhibit NumberDescription
31.1*NumberDescription of Exhibit
31.1 *Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*31.2 *Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**Certification of Principal Executive Officer and Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1*32.2**Press Release, dated November [10], 2017, announcing financial conditionCertification of Principal Financial and resultsAccounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of operations.the Sarbanes-Oxley Act of 2002.
101.INS*Inline XBRL Instance Document
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Filed herewith.
**Furnished herewith.

* Filed herewith.

** Furnished herewith.

1137